Variation in sites of lithiation of substituted N-benzylpivalamides and N'-benzyl-N,N-dimethylureas: application in synthesis by El-Hiti, Gamal et al.
General Papers  ARKIVOC 2009 (xiv) 266-300 
Variation in sites of lithiation of substituted N-benzylpivalamides 
and N'-benzyl-N,N-dimethylureas: application in synthesis 
 
Keith Smith,* Gamal A. El-Hiti,* Amany S. Hegazy, Ahmed Fekri and Benson M. Kariuki 
 
School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff CF10 3AT, UK 
E-mail: smithk13@cardiff.ac.uk, el-hitiga@cardiff.ac.uk
 
 
Abstract 
Directed lithiation of various substituted benzylamines takes different courses depending on the 
substituents at nitrogen and on the aryl ring and/or the nature of the alkyllithiums. Lithiation of 
N-benzylpivalamide with t-BuLi gives a mixture of ring (2-position) and side-chain lithiated 
species, but the 2-lithiated isomer can be obtained cleanly via bromine-lithium exchange of 
N-(2-bromobenzyl)pivalamide. N'-Benzyl-N,N-dimethylurea, N'-(4-substituted benzyl)-N,N-
dimethylureas and N-(4-substituted benzyl)pivalamides give 2-lithiated derivatives directly with 
t-BuLi at -78 °C. By contrast, lithiation of N-(2-methoxybenzyl)pivalamide occurs at the 
6-position, ortho- to the methoxy group, while lithiation of N'-(2-methoxybenzyl)-N,N-
dimethylurea gives a mixture of 2- and 6-lithiated species. All organolithiums are converted in 
high yields to their corresponding substitution products on reactions with various electrophiles. 
 
Keywords: Directed ortho-lithiation, electrophilic substitution, substituted benzylamines, 
synthesis, side-chain lithiation 
 
 
 
Introduction 
 
Regioselective synthesis of substituted aromatics is one of the classical problems in synthetic 
chemistry. Simple electrophilic substitution often leads to various isomers and polysubstituted 
aromatics and usually takes place under forcing conditions in the presence of a catalyst. In recent 
years, many efforts have been made to develop more regioselective processes for production of 
specific products and it is well recognized that organolithium reagents1,2 can play an important 
role in such cases. In particular, lithiation of aromatic compounds often occurs proximal to 
substituents that possess hetero atoms.3 As a result, lithiation of aromatics or heterocycles 
followed by treatment with an electrophile is one of the most efficient approaches for synthesis 
of substituted and/or modified derivatives.4,5
For example, we have developed several efficient lithiation procedures for preparation of 
various substituted aromatics and heteroaromatics that might be difficult to prepare by other 
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means.6 As part of such studies we became interested in directed lithiation of benzylamine 
derivatives. Lithiation of pivaloyl, tert-butoxycarbonyl and dimethylaminocarbonyl derivatives 
has been reported by Schlosser and shows interesting variations in the site(s) of lithiation 
depending on both the N-substituent and on any group present on the aromatic ring.7,8 Notably, 
in several cases mixtures resulting from different sites of lithiation were obtained. It was of 
interest to try to overcome such difficulties and to develop protocols for high yield syntheses of 
specific products.  
Some of Schlosser’s results are summarized in Figure 1, which illustrates that there are four 
possible sites of lithiation for compounds of type 1, in which the lithium is introduced adjacent to 
a para-substituent (product 2), adjacent to the substituted aminomethyl group 3, adjacent to an 
ortho-substituent 4 or on the substituted aminomethyl group 5. 
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Figure 1. Lithiation and substitution of compounds of type 1 reported by Schlosser.7,8 
 
Clearly the situation is rather complicated and it is difficult to draw general conclusions when 
the reagents and conditions used were different for different substrates. We therefore decided to 
undertake a comparative study of the lithiation of various compounds of type 1 (R1 = tBu or 
Me2N; X = H, Me, OMe, Cl, F; Y = H, OMe) under a limited range of conditions in order to 
understand better the various influences. As a result, we have been able to define conditions that 
allow almost quantitative conversion of 1 (R1 = tBu or Me2N; X = H, Me, OMe, Cl, F; Y = H) 
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into products 3, and for quantitative conversion of 1 (R1 = tBu; X = H; Y = OMe) into 
compounds 4. 
In a preliminary communication we reported that directed lithiation of 
N-(2-methoxybenzyl)pivalamide (1; R1 = tBu; X = H; Y = OMe) with two mole equivalents of 
t-BuLi in anhydrous THF at -78 °C followed by reactions with various electrophiles gave ring 
substitution,9 but ortho- to the methoxy group, which was unexpected in view of earlier results 
reported with n-BuLi at 0 °C.7 We now report the full details of that work and the successful 
lithiation and substitution of various other substituted benzylamines using a simple, general and 
efficient lithiation procedure using t-BuLi in THF at low temperatures. 
 
 
Results and Discussion 
 
Substituted N-benzylpivalamides and N'-benzyl-N,N-dimethylureas were prepared in high yields 
from the corresponding substituted benzylamines using standard procedures.10
Initially, N-benzylpivalamide 6 in THF was treated with n-BuLi (2.2 mole equivalents) at -78 °C 
and the reddish solution obtained was stirred for 4 h at -78 °C. Benzophenone in THF was added 
and the mixture was stirred for another 2 h. After warming to room temperature and work-up, the 
product mixture was separated by column chromatography (silica gel; Et2O–hexane, 1:3) to give 
7 and 8 (Scheme 1) in 4 and 7% yields, respectively, along with 6 (81%) and benzophenone. 
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Scheme 1. Lithiation of 6 followed by reaction with benzophenone. 
 
The low yields of 7 and 8 were presumably because lithiation of 6 with n-BuLi at - 78 oC was 
slow. Use of sec-BuLi gave results that were similar to those with n-BuLi. However, use of 
t-BuLi under similar conditions gave 7 and 8 in somewhat better yields (6 and 10%, respectively) 
along with 6 (69%). Therefore, we carried out lithiation with this reagent at different 
temperatures. The results obtained are recorded in Table 1.  
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Table 1. Yields of 7 and 8 from lithiation of 6 using t-BuLi (2.2 mole equivalents) for 4 h at the 
appropriate temperature, followed by reaction with benzophenone according to Scheme 1 
Yield (%)a 
Entry 
 
T (°C) 6 7 8 Total of 7 and 8 
1 -78 69 6 10 16 
2 0 20 37 34 71 
3 20 30 42 17 59 
a Yield of isolated product after purification by column chromatography. 
 
The overall yield was improved at higher temperatures, but was highest at 0 °C (Table 1; 
entry 2) and somewhat lower at 20 °C (entry 3), presumably because of some loss of the t-BuLi 
by reaction with the solvent.11 However, the yield of 7 was actually higher at 20 °C than at 0 °C, 
all of the loss having arisen from a reduction in the yield of 8. Indeed, there was a significant 
change in selectivity, from favouring 8 at low temperature to favouring 7 at higher temperature. 
Presumably, the dilithium reagent leading to 8 is not very stable in THF at 20 °C and either 
converts back to the starting material 6 (by reaction with the solvent) or isomerises to a more 
stable dilithium reagent (presumably the one that leads to 7). To test these possibilities, 
generation of the ring-lithiated material was attempted via bromine-lithium exchange of 
N-(2-bromobenzyl)pivalamide 9. 
Bromine-lithium exchange of 9 took place smoothly with MeLi (to deprotonate the nitrogen) 
and then t-BuLi (bromine-lithium exchange) at -78 °C in THF (Scheme 2). The mixture was 
stirred for 2 h at -78 °C and the dilithium reagent thus obtained was allowed to react with a range 
of electrophiles at -78 °C in THF for 2 h (Scheme 2). Following work-up, the crude products 
obtained were crystallized from EtOAc–Et2O (1:3) to give the corresponding N-(2-substituted 
benzyl)pivalamides 8 and 10-14 (Scheme 2) in high yields (Table 2). 
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Scheme 2. Synthesis of N-(2-substituted benzyl)pivalamides 8 and 10-14 via bromine-lithium 
exchange of 9 followed by reaction with various electrophiles. 
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Table 2. Synthesis of various N-(2-substituted benzyl)pivalamides according to Scheme 2 
Product Electrophile E Yield (%)a
8 Ph2CO Ph2C(OH) 90 
10 (CH2)5C=O (CH2)5C(OH) 90 
11 PhCHO PhCH(OH) 86 
12 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 87 
13 D2O D 91 
14 MeI Me 85 
a Yield of isolated product after crystallization. 
 
As Table 2 shows, the yields of products were high in all cases. The 1H NMR spectra of 
compounds 11 and 12 showed the expected diastereotopicity for the hydrogens of the CH2 group 
at position 1. Clearly bromine-lithium exchange of 9 had occurred smoothly and rapidly at –78 °C. 
Therefore, to test the possibility that the dilithium intermediate might be unstable, a solution was 
prepared as above at –78 °C and then allowed to warm to room temperature (20 °C) and stirred 
for 30 minutes at that temperature before addition of benzophenone. The reaction mixture was 
stirred for 2 h at room temperature and then worked-up. The yield of 8 obtained was significantly 
reduced (to 78%) and the loss was accounted for by the production of 6 (ca. 15%), but no other 
product was obtained. This implies that the low yield of 8 following lithiation of 6 at 20 °C 
results from reaction of the intermediate with solvent to give back 6, rather than isomerisation. 
Attention was next turned to investigate lithiation of N-(4-substituted benzyl)pivalamides 15-
18 using t-BuLi as the lithium reagent. Two mole equivalents of t-BuLi were used at -78 °C in 
THF. The mixtures were stirred for 4 h at -78 °C in an attempt to ensure complete lithiation and 
the solutions obtained were then treated with various electrophiles. Each reaction was conducted 
under identical conditions and then warmed to room temperature and quenched by the addition 
of aq. NH4Cl. The crude products were purified by column chromatography to give the 
corresponding 2-substituted derivatives 19-43 (Scheme 3) in good yields (Table 3). 
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Scheme 3. Synthesis of various substituted N-benzylpivalamides 19-43 via directed lithiations of 
15-18 followed by reactions with electrophiles. 
From the results in Table 3 it is clear that for all four substrates lithiation was rapid at -78 °C 
and that substitution took place almost exclusively at the position ortho- to the CH2NHCOBut 
ISSN 1551-7012 Page 270 ©ARKAT USA, Inc. 
General Papers  ARKIVOC 2009 (xiv) 266-300 
group. This was somewhat surprising in view of the low yield and the mixture of products 
obtained on direct lithiation of the unsubstituted N-benzylpivalamide 6. It would appear that the 
presence of a substituent in the 4-position inhibits deprotonation of the CH2 group while 
promoting deprotonation at the 2-position. Given the different natures of the substituents and the 
relatively small effects those substituents have on 1H and 13C chemical shifts at positions meta to 
them, it not obvious why this should be. However, the results are unequivocal. The structures of 
20, 33 and 40 were confirmed by X-ray crystallography (Figure 2), while the 1H NMR spectra of 
compounds obtained via reactions with aldehydes and unsymmetrical ketones showed that the 
signals of the two hydrogens of the CH2 group appear separately, as two separated double 
doublets that converted to two doublets after addition of D2O, indicating that they are 
diastereotopic. 
 
 
20 
 
33 40 
 
Figure 2. X-Ray crystal structures of compounds 20, 33 and 40. 
 
Table 3. Synthesis of various substituted N-benzylpivalamides 19-43 according to Scheme 3 
Product X Electrophile E Yield (%)a
19 Me 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 81 
20 Me PhCHO PhCH(OH) 79 
21 Me Ph2CO Ph2C(OH) 81 
22 Me (CH2)5C=O (CH2)5C(OH) 82 
23 Me D2O D 88 
24 Me MeI Me 80b
25 Me EtI Et 81 
26 OMe MeI Me 81c
27 OMe Ph2CO Ph2C(OH) 80 
28 OMe (CH2)5C=O (CH2)5C(OH) 77 
29 OMe MeCOBu MeC(OH)Bu 78 
30 OMe 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 82 
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Table 3. Continued 
Product X Electrophile E Yield (%)a 
31 OMe D2O D 88 
32 Cl 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 83 
33 Cl PhCHO PhCH(OH) 82 
34 Cl Ph2CO Ph2C(OH) 79 
35 Cl (CH2)5CO (CH2)5C(OH) 73 
36 Cl EtI Et 79 
37 Cl D2O D 88 
38 F 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 78 
39 F PhCHO PhCH(OH) 79 
40 F Ph2CO Ph2C(OH) 76 
41 F (CH2)5CO (CH2)5C(OH) 82 
42 F EtI Et 82 
43 F D2O D 85 
a Yield of isolated product after purification by column chromatography. 
b Compound 44 (Figure 3) was obtained in 2% yield as a side product and in 88% yield when the 
reaction was repeated with 2.2 equivalents of MeI. 
c Compound 45 (Figure 3) was produced in 5% yield as a side product and in 87% yield when 
the reaction was repeated with 2.2 equivalents of MeI. 
 
Reactions involving MeI as electrophile gave small amounts of N-methylated compounds (44 
and 45, Figure 3) as by-products. These could be obtained in high yields by use of excess MeI. 
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Figure 3. Structures of compounds 44 and 45. 
 
We next turned our attention to N-(2-methoxybenzyl)pivalamide 46. Double lithiation 46 
took place smoothly with t-BuLi (2 equivalents) under the general conditions used previously 
with other substrates. The dilithium reagent produced was allowed to react with various 
electrophiles at -78 °C for 2 h. The reaction mixtures were warmed to room temperature and 
quenched by the addition of aq. NH4Cl. The crude products were purified by column 
chromatography or direct crystallization from ethyl acetate to give the corresponding 
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N-(3-substituted 2-methoxybenzyl)pivalamides 47-51 (Scheme 4) in high yields (Table 4). Small 
quantities of by-products were also obtained in some cases (Table 4 and Figure 4). 
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Scheme 4. Synthesis of N-(3-substituted 2-methoxybenzyl)pivalamides via lithiation of 46. 
 
Table 4. Synthesis of N-(3-substituted 2-methoxybenzyl)pivalamides 47-51 via lithiation and 
substitution of 46 according to Scheme 4 
Product Electrophile E Yield (%)a
47 CO2 CO2H 80b,c
48 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 76d
49 PhCHO PhCH(OH) 75 
50 Ph2CO Ph2C(OH) 73e
51 D2O D 86 
a Yield of isolated product after purification by column chromatography unless otherwise 
indicated. 
b Compound 47 was purified by crystallization from ethyl acetate. 
c The mother liquor showed the presence of 52 (Figure 4) and additional 47 in nearly equal 
proportions along with traces of 46. 
d Compound 53 (Figure 4) was obtained as a by-product in 2% yield.  
e Compound 54 (Figure 4) was obtained as a by-product in 3% yield. 
 
OMe
NHCOBut
Ph
Ph
OH
NHCOBut
OMe
CO2H
NHCOBut
OMe
CO2H
NHCOBut
OH
OMe
MeO
53 5452 55  
 
Figure 4. Structures of compounds 52-55, by-products from reactions according to Scheme 4. 
 
The 1H NMR spectra of 48 and 49 showed the CH2 hydrogens as two separated double 
doublets, indicating that they are diastereotopic. By-product 53 from the reaction with 
4-anisaldehyde was expected to be formed as a mixture of diastereoisomers but its NMR spectra 
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showed what appeared to be single sets of signals, indicating that the isolated product was 
probably a single diastereoisomer. However, since it was isolated in only 2% yield, it is possible 
that a small amount of the other diastereoisomer was formed but not isolated. The structures of 
compounds 47, 48 and 53 were confirmed by X-ray crystallography (Figure 5). 
 
47 48 53 
 
Figure 5. X-ray crystal structures of compounds 47, 48 and 53. 
 
The results in Table 4 clearly showed that compound 46 undergoes lithiation with t-BuLi at 
-78 °C mainly at the position ortho- to the methoxy group, with only a small extent of lithiation 
on the side chain and no evidence for lithiation at the ring position adjacent to the CH2NHCOBut 
group. This was not expected based on the early results reported by Schlosser8 using n-BuLi at 0 °C, 
or based on the results we saw with 16, where lithiation took place next to CH2NHCOBut. 
In order to understand the situation better, lithiation of compound 46 was attempted using 
different lithium reagents (t-BuLi, sec-BuLi and n-BuLi) under different reaction conditions. 
Compound 46 was treated with RLi (2.2 mole equivalents) at -78 or 0 °C and the mixture was 
stirred for 2 h at 0 °C or 4 h at -78 °C. Solid carbon dioxide was added and the reaction mixture 
was stirred for 30 minutes. The mixture was diluted with ethyl acetate and quenched with dilute 
HCl. The crude product was crystallized from ethyl acetate to give the pure products and 
inspection of the 1H NMR spectra of the residual mother liquors allowed the overall yields of all 
components obtained in the reactions to be estimated. The results are presented in Table 5. 
The results showed interesting variations in both rates and product proportions. The extent of 
lithiation at -78 °C ranged from virtually quantitative with t-BuLi to virtually zero with n-BuLi, 
while all three reagents brought about substantial lithiation at 0 °C. Both n-BuLi and sec-BuLi 
gave mixtures indicative of lithiation on the side chain and at the 6-position, as reported by 
Schlosser with n-BuLi.8 There was very little lithiation at the 3-position with these reagents, 
whereas this was predominant with t-BuLi at 0 °C and almost exclusive at -78 °C. It is not clear 
why lithiation of 46 with t-BuLi in THF at -78 °C occurs ortho- to the methoxy group while 
n-BuLi and sec-BuLi give mixtures involving lithiation at two other sites, but it could relate to 
the way the reagents aggregate, their ability to chelate the two substituents, their basicity, or the 
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relative bulk of the alkyl groups. Whatever the explanation, the procedure outlined in Scheme 4 
represents a simple and high yielding route for substitution of 46 ortho- to the methoxy group. 
 
Table 5. Products from lithiation of 46 with RLi and then reaction with carbon dioxide 
Approximate yields of the components of the total product (%)a 
RLi 
 
T (°C) 46 47 52b 55c
t-BuLi -78 2 87 7 — 
t-BuLi 0 — 49 26 19 
sec-BuLi -78 22 — 34 36 
sec-BuLi 0 9 — 38 48 
n-BuLi -78 97 — — — 
n-BuLi 0 17 8 40 30 
a By combination of weights of the crystallised materials and the quantities estimated by 1H 
NMR to be present in the mother liquors. 
b No attempt was made to isolate a pure sample of 52. 
c The structure of 55 was confirmed by X-ray crystallography (Figure 6). 
 
 
55 66 
 
71 
Figure 6. X-Ray crystal structures of compounds 55, 66 and 71. 
 
Attention was next turned to investigate lithiation of various N'-benzyl-N,N-dimethylureas 
56-60 under the general conditions used previously with N-benzylpivalamides 15-18. The 
mixtures were stirred with t-BuLi for 4 h at -78 °C in an attempt to ensure complete lithiation 
and then treated with various electrophiles, warmed to room temperature and quenched by the 
addition of aq. NH4Cl. The crude products were purified by column chromatography to give the 
corresponding 2-substituted derivatives 61-82 (Scheme 5) in good yields (Table 6). 
From the results in Table 6 it is clear that for all substrates, including the unsubstituted one, 
substitution took place almost exclusively at the position ortho- to the urea-containing group. 
The 1H NMR spectra of compounds obtained via reactions with aldehydes and unsymmetrical 
ketones showed that the signals of the two hydrogens of the CH2 group appear separately, as two 
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separated double doublets that converted to two doublets after addition of D2O, indicating that 
they are diastereotopic. The structures of 66 and 71 were confirmed by X-ray crystallography 
(Figure 6). 
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Scheme 5. Synthesis of various substituted N'-benzyl-N,N-dimethylureas 61-82. 
 
Table 6. Synthesis of substituted N'-benzyl-N,N-dimethylureas 61-82 according to Scheme 5 
Product X Electrophile E Yield (%)a
61 H 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 86 
62 H PhCHO PhCH(OH) 82 
63 H Ph2CO Ph2C(OH) 84 
64 H MeI Me 80 
65 H D2O D 89 
66 Me 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 76 
67 Me PhCHO PhCH(OH) 70 
68 Me Ph2CO Ph2C(OH) 72 
69 Me EtI Et 80 
70 Me D2O D 86 
71 OMe 4-MeOC4H6CHO 4-MeOC4H6CH(OH) 85 
72 OMe PhCHO PhCH(OH) 89 
73 OMe Ph2CO Ph2C(OH) 84 
74 OMe D2O D 86 
75 OMe EtI Et 88b
76 Cl 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 79 
77 Cl PhCHO PhCH(OH) 79 
78 Cl EtI Et 78 
79 Cl D2O D 79 
80 F 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 83 
81 F PhCHO PhCH(OH) 83 
82 F D2O D 86 
a Yield of isolated product after purification by column chromatography. 
b N'-Ethyl-N'-(2-ethyl-4-methoxybenzyl)-N,N-dimethylurea 83 was obtained in 3% yield, as a 
side-product and in 90% yield when the reaction was repeated with 2.2 equivalents of EtI. 
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In contrast to the situation with the corresponding pivalamide, lithiation of 
N'-(2-methoxybenzyl)-N,N-dimethylurea (84, Scheme 6) under the above conditions, and then 
reaction with 4-anisaldehyde and separation by column chromatography, gave N'-(2-(hydroxy(4-
methoxyphenyl)methyl)-6-methoxybenzyl)-N,N-dimethylurea (85; 29%) and N'-(3-(hydroxy-(4-
methoxyphenyl)methyl)-2-methoxybenzyl)-N,N-dimethylurea (86; 26%), along with 84 (39%). 
The sites of lithiation were the ones expected based on Schlosser’s findings with an unspecified 
reagent, but in the earlier work no pure products were separated from the reaction mixture.7 It 
was of interest to see if the reaction would proceed in the same manner under different 
conditions. Therefore, a more detailed study was conducted using t-BuLi with different reaction 
times and temperatures (Scheme 6). The results obtained are recorded in Table 7. 
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Scheme 6. Lithiation of 84 followed by reaction with 4-anisaldehyde. 
 
Table 7. Yields from reaction according to Scheme 6 under various conditions 
Yield (%)a
Entry T (°C) Time (h) 
Lithiation 84 85 86 
1 –78 2 39 29 26 
2 –78 4 34 31 27 
3 –50 2 13 35 33 
4 –50 4 13 36 34 
5 –20 2 — 49 40 
a Yield of isolated products after purification. 
 
It was found that at higher temperatures the yields of 85 and 86 were higher than at -78 °C 
while less of 84 was recovered. At -20 °C no starting material remained and the total yield was 
good, but there was no significant change in selectivity. Clearly, direct lithiation of 84 on the 
ring ortho to the urea containing group without lithiation ortho to the methoxy group was not a 
realistic hope. Both substitution sites were attacked competitively. It was nevertheless of interest 
to see if the reaction of 84 would be general and useful. Therefore, lithiation of 84 using t-BuLi 
at –20 °C in THF for 2 h was followed by reactions with various electrophiles for 2 h at -20 °C. 
The mixtures were separated by column chromatography to give N'-(2-substituted 
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6-methoxybenzyl)-N,N-dimethylureas, 85, 87, 89, 91 and 93, and N'-(3-substituted 
2-methoxybenzyl)-N,N-dimethylureas, 86, 88, 90, 92 and 94 (Scheme 7), in high overall yields 
(Table 8). 
 
N
H
N
O
OMe
N
H
N
O
OMe
E
NN
H
O
OMe
E
1, 2.2  t-BuLi, -20 °C, 2 h
2, Electrophile, -20 °C, 2 h
3, aq. NH4Cl
84 85, 87, 89, 91 and 93
+
86, 88, 90, 92 and 94  
 
Scheme 7. Synthesis of N'-(substituted methoxybenzyl)-N,N-dimethylureas 85-94 via lithiation 
and substitution of 84. 
 
Table 8. Synthesis of 85-94 according to Scheme 7 
Product (Yield %)aElectrophile E 
2-Substituted- 6-Substituted- 
Overall 
yield (%) 
4-MeOC6H4CHO 4-MeOC6H4CH(OH) 85 (49) 86 (40) 89 
PhCHO PhCH(OH) 87 (51) 88 (38) 89 
Ph2CO Ph2C(OH) 89 (47) 90 (30) 77 
MeIb Me 91 (51) 92 (40) 91 
EtI Et 93 (51) 94 (38) 89 
a Yield of isolated products after purification by column chromatography. 
b A mixture of 95 and 96 (Figure 7), which was difficult to separate, was also obtained, in 5% 
yield. 
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Figure 7. Structures of by-products 95 and 96. 
 
From the results recorded in Table 8 it is clear that different electrophiles give the 
corresponding products in comparable yields. The 1H NMR spectra of compounds 85-88 showed 
two separate double doublets for the diastereotopic hydrogens of the CH2 groups. 
 
 
 
Conclusions 
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A simple, efficient and high yielding lithiation procedure that allows electrophilic substitution of 
various substituted benzylamines has been demonstrated. Lithiation of N-benzylpivalamide with 
t-BuLi gave a mixture derived from lithiation at ring position 2 (ortho-substitution) and on the 
side-chain CH2 group (α-substitution). Exclusive ring substitution could be achieved via 
bromine-lithium exchange of N-(2-bromobenzyl)pivalamide and subsequent reactions with 
electrophiles to give the corresponding N-(2-substituted benzyl)pivalamides in high yields. 
Lithiation of N-(4-substituted benzyl)pivalamides, unsubstituted N'-benzyl-N,N-dimethylurea 
and N'-(4-substituted benzyl)-N,N-dimethylureas with t-BuLi in THF at -78 °C followed by 
reactions with a variety of electrophiles gave high yields of products involving substitution at the 
2-position. Unexpectedly, N-(2-methoxybenzyl)pivalamide undergoes lithiation ortho- to the 
methoxy group with t-BuLi at -78 °C, while use of n-BuLi or sec-BuLi under similar conditions 
gives almost no lithiation at this position, leading instead to competitive lithiation on the side-
chain (pivaloylaminomethyl group) and ortho- to the pivaloylaminomethyl group. By contrast, 
lithiation of N'-(2-methoxybenzyl)-N,N-dimethylurea with t-BuLi at -20 °C in THF followed by 
reactions with a range of electrophiles gives mixtures of products involving ring substitution 
both next to the methoxy group (o'-substitution) and next to the urea containing group 
(o-substitution).  
Clearly, all factors can be significant in determining the position of substitution in such 
systems and the right choice of lithiating agent, substituent group and reaction conditions are 
necessary in order to ensure that the desired product is obtained. 
 
 
Experimental Section 
 
General. Melting point determinations were performed by the open capillary method using a 
Gallenkamp melting point apparatus and are reported uncorrected. 1H and 13C NMR spectra were 
recorded on a Bruker AV400 or AV500 spectrometer operating at 400 or 500 MHz for 1H or 100 
and 125 MHz for 13C measurements. Chemical shifts δ are reported in parts per million (ppm) 
relative to TMS and coupling constants J are in Hz and have been rounded to the nearest whole 
number. 13C multiplicities were revealed by DEPT signals. Assignments of signals are based on 
integration values, coupling patterns and expected chemical shift values and have not been 
rigorously confirmed. Signals with similar characteristics might be interchanged. Low-resolution 
mass spectra (see supplementary information) were recorded on a Quattro II spectrometer, 
electron impact (EI) at 70 eV and chemical ionization (CI) at 50 eV by the use of NH3 as 
ionization gas. Atmospheric pressure chemical ionization mass spectra (APCI) were performed 
on a Waters LCT Premier XE instrument. Electrospray (ES) analyses were performed on a 
ZQ4000 spectrometer in positive and negative ionisation modes. Accurate mass data were 
obtained on a MAT900 instrument. IR spectra (see supplementary information) were recorded on 
a Perkin Elmer Spectrum One FT-IR spectrometer or a Perkin Elmer 1600 series FT-IR 
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Spectrometer. Microanalyses were performed by Warwick analytical service at the University of 
Warwick. The X-ray single-crystal diffraction data were collected on a Nonius Kappa CCD 
diffractometer using graphite-monochromated Mo-Kα, (λ = 0.710 73 Å) radiation. Crystal and 
structure refinement data are shown in the supplementary information. The structures were 
solved by direct methods using SHELXS-9612 and refined with all data on F2 full-matrix least 
squares using SHELXL-97.13 Non-hydrogen atoms were generally refined anisotropically. 
Hydrogen atom positions were located from difference Fourier maps and a riding model with 
atomic displacement parameters 1.2 times (1.5 times for methyl groups) those of the atom to 
which they are bonded was used for subsequent refinements. Despite the poor quality of the 
crystals of 53 the structural results obtained are good enough to support the conclusions reached 
in the discussion. Full crystallographic data have been deposited with the CCDC, reference 
numbers 736581-736588 and 736920, and can be obtained free of charge via 
http://www.ccdc.ac.uk/data_request/cif. Column chromatography was carried out using Fischer 
Scientific silica 60A (35-70 micron). Alkyllithiums were obtained from Aldrich Chemical 
Company and were estimated prior to use by the method of Watson and Eastham.14 Other 
chemicals were obtained from Aldrich Chemical Company and used without further purification. 
THF was distilled from sodium benzophenone ketyl. Other solvents were purified by standard 
procedures.15 
 
General procedure for the lithiation and substitution of N-benzylpivalamide (6) 
A solution of t-BuLi in pentane (2.6 mL, 1.7 M, 4.4 mmol) was added to a stirred solution of 6 
(0.38 g, 2.0 mmol) at the appropriate temperature (–78, 0 or 20 °C) in THF (20 mL) under N2. 
The mixture was stirred at the appropriate temperature for 2–4 h and a solution of benzophenone 
(0.40 g, 2.2 mmol) in THF (8 mL) was added. The reaction mixture was stirred for 2 h at the 
appropriate temperature, and then allowed to warm to room temperature if the reaction was 
carried out at low temperature. It was then diluted with EtOAc (20 mL) and quenched with aq. 
sat. NH4Cl (20 mL). Following work-up, the residue obtained was purified by column 
chromatography (silica gel; Et2O–hexane, 1:3) to give the pure products 7 and 8. The yields 
obtained of 7 and 8 under various reaction conditions are recorded in Table 1. 
N-(2-Hydroxy-1,2,2-triphenylethyl)pivalamide (7). 44 mg–0.31 g (0.12–0.83 mmol, 6–42%). 
Mp 229–230 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.58 (d, J = 9 Hz, exch., 1 H, NH), 7.55–
7.02 (m, 15 H, 3 Ph), 6.21 (br, exch., 1 H, OH), 5.88 (d, J = 9 Hz, 1 H, CH), 0.92 [s, 9 H, 
C(CH3)3]. 13C NMR (100 MHz, DMSO-d6): δ = 177.0 (C=O), 147.5 (C-1 of Ph), 145.9 (C-1 of 
Ph), 140.6 (C-1), 129.9 (C-3/C-5), 128.6, 128.2 (C-3/C-5 of 2 Ph), 127.6 (C-2/C-6), 127.4 (C-4), 
127.1, 126.7 (C-2/C-6 of 2 Ph), 127.0, 126.9 (C-4 of 2 Ph), 80.7 (C-OH), 59.9 (CH), 38.8 
[C(CH3)3], 27.9 [C(CH3)3]. HRMS (CI): m/z calcd for C25H28NO2 [MH]+: 374.2115; found: 
374.2114. Anal. Calcd for C25H27NO2: C, 80.40; H, 7.29; N, 3.75. Found: C, 80.41; H, 7.27; N, 
3.76. 
N-(2-(Hydroxydiphenylmethyl)benzyl)pivalamide (8). 74 mg–0.25 g (0.20–0.67 mmol, 10–
34%). Mp 218–219 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.85 (t, J = 6 Hz, exch., 1 H, NH), 
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7.35–7.32 (m, 5 H, H-4 and H-3/H-5 of 2 Ph), 7.28–7.23 (m, 7 H, H-6 and H-2/H-6 and H-4 of 2 
Ph), 7.08–7.04 (m, 2 H, H-5 and OH), 6.53 (d, J = 8 Hz, 1 H, H-3), 4.02 (d, J = 6 Hz, 2 H, CH2), 
1.08 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, DMSO-d6): δ = 178.5 (C=O), 148.5 (C-1 of 2 Ph), 
145.3 (C-1), 140.2 (C-2), 129.7 (C-3), 129.4 (C-6), 128.6 (C-3/C-5 of 2 Ph), 128.4 (C-4), 128.3 
(C-2/C-6 of 2 Ph), 127.6 (C-4 of 2 Ph), 126.4 (C-5), 82.3 (C-OH), 41.9 (CH2), 38.8 [C(CH3)3], 
28.2 [C(CH3)3]. HRMS (EI): m/z calcd for C25H27NO2 [M]+: 373.2036; found: 373.2043. 
 
N-(2-Substituted benzyl)pivalamides 8 and 10-14 
To a cooled solution (–78 °C) of N-(2-bromobenzyl)pivalamide (9; 0.54 g, 2.0 mmol) in 
anhydrous THF (20 mL) under a nitrogen atmosphere was added a solution of MeLi in Et2O (2.2 
mL, 1.0 M, 2.2 mmol), in order to deprotonate the nitrogen. The mixture was stirred for 10 min 
at –78 °C. Bromine-lithium exchange was then effected by the addition of t-BuLi in heptane (2.6 
mL, 1.7 M, 4.4 mmol). The mixture was stirred at -78 °C for 2 h, to ensure the complete 
formation of the dilithium reagent, after which an electrophile (2.2 mmol), in anhydrous THF (8 
mL) if solid, otherwise neat, was added. The mixture was stirred for 2 h at -78 °C then the 
cooling bath was removed and the mixture allowed to warm to room temperature. Following 
work-up, the crude product obtained was purified by crystallization from EtOAc–Et2O (1:3) to 
give a white solid. The yields obtained are recorded in Table 2. 
N-(2-(Hydroxydiphenylmethyl)benzyl)pivalamide (8). 0.67 g (1.80 mmol, 90%). Mp 218–219 
°C. The material produced was found to be identical in all respects with the one produced from 
ring lithiation of 6 followed by reaction with benzophenone. 
N-(2-(1-Hydroxycyclohexyl)benzyl)pivalamide (10). Yield: 0.52 g (1.80 mmol, 90%). Mp 
127–128 °C. 1H NMR (400 MHz, CDCl3): δ = 7.38–7.35 (m, 2 H, H-3 and H-5), 7.28–7.19 (m, 2 
H, H-4 and H-6), 6.67 (br, exch., 1 H, NH), 4.73 (d, J = 5 Hz, 2 H, CH2N), 2.89 (s, exch., 1 H, 
OH), 2.00-1.68 [m, 10 H, (CH2)5], 1.16 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 
178.5 (C=O), 146.7 (C-2), 137.7 (C-1), 132.5 (C-6), 127.7 (C-3), 127.6 (C-4), 126.0 (C-5), 75.0 
(C-1 of cyclohexyl), 43.2 (CH2NH), 39.2 (C-2/C-6 of cyclohexyl), 38.9 [C(CH3)3], 27.9 
[C(CH3)3], 25.7 (C-4 of cyclohexyl), 22.4 (C-3/C-5 of cyclohexyl). HRMS (CI): m/z calcd for 
C18H28NO2 [MH]+: 290.2115; found: 290.2116.  
N-(2-(Hydroxyphenylmethyl)benzyl)pivalamide (11). 0.51 g (1.72 mmol, 86%). Mp 138–139 
°C. 1H NMR (400 MHz, DMSO-d6): δ = 7.90 (app. t, J = 6 Hz, exch., 1 H, NH), 7.45 (dd, J = 2, 
8 Hz, 1 H, H-6), 7.33–7.14 (m, 8 H, H-3, H-4, H-5 and Ph), 5.95 (d, J = 5 Hz, exch., 1 H, OH), 
5.91 (d, J = 5 Hz, 1 H, CH), 4.34 (dd, J = 6, 16 Hz, 1 H, CHaHb), 4.17 (dd, J = 6, 16 Hz, 1 H, 
CHaHb), 1.13 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, DMSO-d6): δ = 178.1 (C=O), 145.2 (C-1 
of Ph), 143.1 (C-1), 137.4 (C-2), 128.9 (C-3/C-5 of Ph), 127.8 (C-2/C-6 of Ph), 127.7 (C-4 of 
Ph), 127.6 (C-3), 127.5 (C-4), 127.4 (C-5), 127.3 (C-6), 71.7 (CH), 40.2 (CH2), 38.9 [C(CH3)3], 
28.3 [C(CH3)3]. HRMS: m/z calcd for C19H24NO2 [MH]+: 298.1802; found: 298.1805.  
N-(2-(Hydroxy-(4-methoxyphenyl)methyl)benzyl)pivalamide (12). 0.57 g (1.74 mmol, 87%). 
Mp 164–166 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.87 (app. t, J = 5 Hz, exch., 1 H, NH), 
7.48 (dd, J = 2, 8 Hz, 1 H, H-6), 7.27–7.20 (m, 4 H, H-4, H-5 and H-2/H-6 of 4-methoxyphenyl), 
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7.13 (d, J = 8 Hz, 1 H, H-3), 6.89 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 5.88 (d, J = 4 
Hz, exch., 1 H, OH), 5.79 (d, J = 4 Hz, 1 H, CH), 4.33 (dd, J = 5, 16 Hz, 1 H, CHaHb), 4.10 (dd, 
J = 5, 16 Hz, 1 H, CHaHb), 3.73 (s, 3 H, OCH3), 1.13 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, 
DMSO-d6): δ = 177.6 (C=O), 158.5 (C-4 of 4-methoxyphenyl), 142.8 (C-1), 142.7 (C-2), 136.7 
(C-1 of 4-methoxyphenyl), 128.6 (C-2/C-6 of 4-methoxyphenyl), 127.0 (C-3), 126.9 (C-6), 126.8 
(C-4), 126.7 (C-5), 114.1 (C-3/C-5 of 4-methoxyphenyl), 70.8 (CH), 55.4 (OCH3), 39.8 (CH2), 
38.4 [C(CH3)3], 27.8 [C(CH3)3]. HRMS (CI): m/z calcd for C20H25NO3 [MH]+: 328.1907; found: 
328.1908. Anal. Calcd for C20H25NO3: C, 73.37; H, 7.71; N, 4.22. Found: C, 73.37; H, 7.70; N, 
4.28. 
N-(2-(Deuteriobenzyl)pivalamide (13). 0.35 g (1.82 mmol, 91%). Mp 81–82 °C (Mp of 
undeuteriated analogue 79–78 °C16). 1H NMR (400 MHz, CDCl3): δ = 7.27–7.23 (m, 2 H, H-3 
and H-5), 7.21–7.17 (m, 2 H, H-4 and H-6), 5.92 (br, exch., 1 H, NH), 4.35 (d, J = 4 Hz, 2 H, 
CH2), 1.15 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.6 (C=O), 139.0 (C-1), 129.1 
(C-4), 129.0 (C-6), 128.0 (C-3), 127.8 (C-5), 127.5 (seen as three lines, 1:1:1, because of 
coupling to D, C-2), 43.8 (CH2), 39.1 [C(CH3)3], 28.0 [C(CH3)3]. HRMS (CI): m/z calcd for 
C12H17DNO [MH]+: 193.1446; found: 193.1445.  
N-(2-Methylbenzyl)pivalamide (14). 0.35 g, (1.70 mmol, 85%). Mp 108–109 °C. 1H NMR (400 
MHz, CDCl3): δ = 7.07–7.02 (m, 4 H, H-3, H-4, H-5 and H-6), 5.65 (br, exch., 1 H, NH), 4.29 
(d, J = 5 Hz, 2 H, CH2), 2.17 (s, 3 H, CH3), 1.09 [s, 9 H, C(CH3)3].13C NMR (400 MHz, CDCl3): 
δ = 178.5 (C=O), 136.9 (C-1), 136.6 (C-2), 130.9 (C-3), 128.8 (C-6), 128.1 (C-4), 126.6 (C-5), 
42.3 (CH2), 39.2 [C(CH3)3], 28.0 [C(CH3)3], 19.3 (CH3). HRMS (CI): m/z calcd for C13H20NO 
[MH]+: 206.1539; found: 206.1542. 
 
General procedure for the lithiation of substituted N-benzylpivalamides and N'-benzyl-
N,N-dimethylureas and subsequent reactions with electrophiles 
A solution of t-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a cold (-78 °C), stirred 
solution of the appropriate substituted benzylamine (2.0 mmol) in anhydrous THF (20 mL) under 
N2. Formation of the dilithium reagent was observed as a brownish solution. The mixture was 
stirred at –78 °C for 4 h, to ensure the complete formation of the dilithium reagent, after which 
an electrophile (2.2 mmol), in anhydrous THF (8 mL) if solid, otherwise neat, was added. The 
mixture was stirred for 2 h at –78 °C then the cooling bath was removed and the mixture allowed 
to warm to room temperature. It was diluted with Et2O (10 mL) and quenched with aq. sat. 
NH4Cl (10 mL). The organic layer was separated, washed with H2O (2 x 10 mL), dried (MgSO4), 
and evaporated under reduced pressure. The residue obtained was purified by column 
chromatography (silica gel; Et2O–hexane, 1:3) to give the corresponding pure products. In the 
case of carbon dioxide as electrophile the procedure was slightly different – see specific cases 
(47 and 55) for details. 
N-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methylbenzyl)pivalamide (19). 0.55 g (1.61 
mmol, 81%). Mp 184–186 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.55 (app. t, J = 6 Hz, exch., 
1 H, NH), 7.05 (s, 1 H, H-3), 6.96 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 6.78 (br, 2 
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H, H-5 and H-6), 6.62 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 5.60 (d, J = 4 Hz, 1 H, 
CH), 5.51 (d, J = 4 Hz, exch., 1 H, OH), 4.02 (dd, J = 6, 15 Hz, 1 H, CHaHb), 3.79 (dd, J = 6, 15 
Hz, 1 H, CHaHb), 3.48 (s, 3 H, OCH3), 2.03 (s, 3 H, CH3), 0.86 [s, 9 H, C(CH3)3]. 13C NMR (100 
MHz, DMSO-d6): δ = 178.0 (C=O), 158.9 (C-4 of 4-methoxyphenyl), 143.2 (C-2), 137.3 (C-1), 
136.1 (C-4), 134.2 (C-1 of 4-methoxyphenyl), 129.0 (C-2/C-6 of 4-methoxyphenyl), 128.1 (C-3), 
128.0 (C-6), 127.7 (C-5), 114.2 (C-3/C-5 of 4-methoxyphenyl), 71.3 (CH), 55.9 (OCH3), 40.0 
(CH2), 38.9 [C(CH3)3], 28.3 [C(CH3)3], 21.8 (CH3). HRMS (ES–): m/z calcd for C21H26NO3 [M – 
1]–: 340.1918; found: 340.1908.  
N-(2-(Hydroxyphenymethyl)-4-methylbenzyl)pivalamide (20). 0.49 g (1.58 mmol, 79%). Mp 
150–151 °C. 1H NMR (400 MHz, CDCl3): δ = 7.28–7.06 (m, 7 H, Ph, H-3 and H-6), 7.00 (dd, J 
= 2, 8 Hz, 1 H, H-5), 5.99 (br t, exch., 1 H, NH), 5.92 (br, 1 H, CH), 4.29 (dd, J = 5, 14 Hz, 1 H, 
CHaHb), 4.16 (dd, J = 5, 14 Hz, 1 H, CHaHb), 3.40 (br, exch., 1 H, OH), 2.23 (s, 3 H, CH3), 0.97 
[s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.7 (C=O), 143.9 (C-1 of Ph), 141.8 (C-
2), 137.9 (C-1), 133.7 (C-4), 130.7 (C-3), 129.4 (C-6), 129.3 (C-5), 128.9 (C-3/C-5 of Ph), 127.8 
(C-4 of Ph), 127.1 (C-2/C-6 of Ph), 74.1 (CH), 41.1 (CH2), 38.9 [C(CH3)3], 27.8 [C(CH3)3], 21.6 
(CH3). HRMS (ES+): m/z calcd for C20H26NO2 [MH]+: 312.1958; found: 312.1960. Anal. Calcd 
for C20H25NO2: C, 77.14; H, 8.09; N, 4.50. Found: C, 77.23; H, 8.14; N, 4.45. 
N-(2-(Hydroxydiphenylmethyl)-4-methylbenzyl)pivalamide (21). 0.63 g (1.63 mmol, 81%). 
Mp 244–246 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.81 (br t, exch., 1 H, NH), 7.34–7.24 (m, 
10 H, 2 Ph), 7.17 (d, J = 8 Hz, 1 H, H-6), 7.08 (d, J = 8 Hz, 1 H, H-5), 7.05 (s, 1 H, H-3), 6.36 (s, 
exch., 1 H, OH), 3.93 (d, J = 5 Hz, 2 H, CH2), 2.08 (s, 3 H, CH3), 1.07 [s, 9 H, C(CH3)3]. 13C 
NMR (100 MHz, DMSO-d6): δ = 178.4 (C=O), 148.6 (C-1 of 2 Ph), 145.3 (C-2), 137.1 (C-1), 
135.2 (C-4), 130.4 (C-3), 129.7 (C-6), 129.0 (C-5), 128.6 (C-3/C-5 of 2 Ph), 128.3 (C-2/C-6 of 2 
Ph), 127.5 (C-4 of 2 Ph), 82.2 (C-OH), 41.7 (CH2), 38.7 [C(CH3)3], 28.2 [C(CH3)3], 21.8 (CH3). 
HRMS (CI): m/z calcd for C26H30NO2 [MH]+: 388.2271; found: 388.2266.  
N-(2-(1-Hydroxycyclohexyl)-4-methylbenzyl)pivalamide (22). 0.50 g (1.65 mmol, 82%). Mp 
127–129 °C. 1H NMR (400 MHz, CDCl3): δ = 7.15 (d, J = 8 Hz, 1 H, H-6), 7.08 (s, 1 H, H-3), 
6.93 (d, J = 8 Hz, 1 H, H-5), 6.57 (br t, exch., 1 H, NH), 4.59 (d, J = 5 Hz, 2 H, CH2N), 2.85 (br 
s, exch., 1 H, OH), 2.24 (s, 3 H, CH3), 1.89–1.59 [m, 10 H, (CH2)5], 1.06 [s, 9 H, C(CH3)3]. 13C 
NMR (100 MHz, CDCl3): δ = 178.4 (C=O), 146.6 (C-2), 137.1 (C-1), 134.6 (C-4), 132.6 (C-3), 
128.3 (C-6), 126.8 (C-5), 75.0 (C-1 of cyclohexyl), 43.0 (CH2NH), 39.2 (C-2/C-6 of cyclohexyl), 
38.9 [C(CH3)3], 27.9 [C(CH3)3], 25.8 (C-4 of cyclohexyl), 22.4 (C-3/C-5 of cyclohexyl), 21.7 
(CH3). HRMS (CI): m/z calcd for C19H30NO2 [MH]+: 304.2271; found: 304.2275.  
N-(2-Deuterio-4-methylbenzyl)pivalamide (23). 0.39 g (1.76 mmol, 88%). Mp 96–97 °C (Mp 
of undeuteriated analogue 94–96 °C17). 1H NMR (400 MHz, CDCl3): δ = 7.18–7.05 (m, 3 H, H-
3, H-5 and H-6), 5.84 (br, exch., 1 H, NH), 4.03 (d, J = 5 Hz, 2 H, CH2), 2.26 (s, 3 H, CH3), 1.14 
[s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.6 (C=O), 137.5 (C-1), 135.9 (C-4), 
129.8 (C-3), 129.7 (C-5), 128.1 (C-6), 127.8 (seen as three lines, 1:1:1, because of coupling to D, 
C-2), 43.7 (CH2), 39.1 [C(CH3)3], 28.0 [C(CH3)3], 21.5 (CH3). HRMS (CI): m/z calcd for 
C13H19DNO [MH]+: 207.1602; found: 207.1598. 
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N-(2,4-Dimethylbenzyl)pivalamide (24). 0.35 g (1.60 mmol, 80%). Mp 95–97 °C. 1H NMR 
(400 MHz, CDCl3): δ = 7.01 (d, J = 8 Hz, 1 H, H-6), 6.93 (s, 1 H, H-3), 6.90 (d, J = 8 Hz, 1 H, 
H-5), 5.63 (br, exch., 1 H, NH), 4.30 (d, J = 5 Hz, 2 H, CH2), 2.23 (s, 3 H, CH3), 2.19 (s, 3 H, 
CH3), 1.13 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.4 (C=O), 137.8 (C-1), 136.9 
(C-2), 133.5 (C-4), 131.8 (C-3), 129.1 (C-6), 127.2 (C-5), 42.2 (CH2), 39.1 [C(CH3)3], 28.1 
[C(CH3)3], 21.4 (CH3), 19.3 (CH3). HRMS (CI): m/z calcd for C14H22NO [MH]+: 220.1696; 
found: 220.1693. 
N-(2-Ethyl-4-methylbenzyl)pivalamide (25). 0.38 g (1.63 mmol, 81%). Mp 88–89 °C. 1H 
NMR (400 MHz, CDCl3): δ = 7.03 (d, J = 8 Hz, 1 H, H-6), 6.97 (s, 1 H, H-3), 6.92 (d, J = 8 Hz, 
1 H, H-5), 5.60 (br, exch., 1 H, NH), 4.33 (d, J = 5 Hz, 2 H, CH2N), 2.54 (q, J = 7 Hz, 2 H, 
CH2CH3), 2.26 (s, 3 H, CH3), 1.13 [s, 9 H, C(CH3)3], 1.11 (t, J = 7 Hz, 3 H, CH2CH3). 13C NMR 
(100 MHz, CDCl3): δ = 178.4 (C=O), 143.0 (C-1), 138.1 (C-2), 132.8 (C-4), 130.1 (C-3), 129.5 
(C-6), 126.8 (C-5), 41.6 (CH2), 39.1 [C(CH3)3], 28.0 [C(CH3)3], 25.7 (CH2CH3), 21.5 (CH3), 
16.0 (CH2CH3). HRMS (CI): m/z calcd for C15H24NO [MH]+: 234.1852; found: 234.1854.  
N-(4-Methoxy-2-methylbenzyl)pivalamide (26). 0.38 g (1.62 mmol, 81%). Mp 93–94 °C. 1H 
NMR (400 MHz, CDCl3): δ = 7.04 (d, J = 8 Hz, 1 H, H-6), 6.66 (d, J = 2 Hz, 1 H, H-3), 6.62 
(dd, J = 2, 8 Hz, 1 H, H-5), 5.64 (br, exch., 1 H, NH), 4.27 (d, J = 5 Hz, 2 H, CH2), 3.70 (s, 3 H, 
OCH3), 2.20 (s, 3 H, CH3), 1.12 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.4 
(C=O), 159.5 (C-4), 138.5 (C-2), 130.4 (C-6), 128.7 (C-1), 116.7 (C-3), 115.5 (C-5), 55.6 
(OCH3), 41.9 (CH2), 39.1 [C(CH3)3], 28.0 [C(CH3)3], 19.6 (CH3). HRMS (CI): m/z calcd for 
C14H22NO2 [MH]+: 236.1645; found: 236.1646.  
N-(2-(Hydroxydiphenylmethyl)-4-methoxybenzyl)pivalamide (27). 0.64 g (1.60 mmol, 80%). 
Mp 205–207 °C. 1H NMR (400 MHz, CDCl3): δ = 7.35–7.25 (m, 11 H, H-6 and 2 Ph), 6.79 (dd, 
J = 2, 8 Hz, 1 H, H-5), 6.41 (t, J = 6 Hz, exch., 1 H, NH), 6.26 (d, J = 2 Hz, 1 H, H-3), 5.22 (s, 
exch., 1 H, OH), 4.08 (d, J = 6 Hz, 2 H, CH2), 3.63 (s, 3 H, OCH3), 1.05 [s, 9 H, C(CH3)3]. 13C 
NMR (100 MHz, CDCl3): δ = 178.8 (C=O), 158.1 (C-4), 147.7 (C-1 of 2 Ph), 146.7 (C-2), 132.8 
(C-6), 131.1 (C-1), 128.4 (C-3/C-5 of 2 Ph), 128.2 (C-2/C-6 of 2 Ph), 127.6 (C-4 of 2 Ph), 117.1 
(C-3), 112.8 (C-5), 82.9 (C-OH), 55.4 (OCH3), 41.9 (CH2), 38.8 [C(CH3)3], 27.8 [C(CH3)3]. 
HRMS (ES+): m/z calcd for C26H29NO3Na [M + Na]+: 426.2040; found: 426.2041.  
N-(2-(1-Hydroxycyclohexyl)-4-methoxybenzyl)pivalamide (28). 0.49 g (1.54 mmol, 77%). 
Mp: 109–110 °C. 1H NMR (400 MHz, CDCl3): δ = 7.21 (d, J = 8 Hz, 1 H, H-6), 6.83 (d, J = 2 
Hz, 1 H, H-3), 6.64 (dd, J = 2, 8 Hz, 1 H, H-5), 6.56 (br t, exch., 1 H, NH), 4.55 (d, J = 6 Hz, 2 
H, CH2), 3.70 (s, 3 H, OCH3), 2.72 (s, exch., 1 H, OH), 1.89–1.61 [m, 10 H, (CH2)5], 1.06 [s, 9 
H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.4 (C=O), 158.9 (C-4), 148.4 (C-2), 133.8 
(C-6), 129.8 (C-1), 113.1 (C-3), 111.5 (C-5), 74.9 (C-1 of cyclohexyl), 55.6 (OCH3), 42.7 
(CH2NH), 39.1 (C-2/C-6 of cyclohexyl), 38.9 [C(CH3)3], 27.9 [C(CH3)3], 25.7 (C-4 of 
cyclohexyl), 22.4 (C-3/C-5 of cyclohexyl). HRMS (CI): m/z calcd for C19H30NO3 [MH]+: 
320.2220; found: 320.2225.  
N-(2-(2-Hydroxyhexan-2-yl)-4-methoxybenzyl)pivalamide (29). 0.50 g (1.56 mmol, 78%). 
Mp 102–103 °C. 1H NMR (400 MHz, CDCl3): δ = 7.20 (d, J = 8 Hz, 1 H, H-6), 6.72 (d, J = 2 
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Hz, 1 H, H-3), 6.68 (br, exch., 1 H, NH), 6.64 (dd, J = 2, 8 Hz, 1 H, H-5), 4.54 (dd, J = 6, 14 Hz, 
1 H, CHaHbNH), 4.50 (dd, J = 5, 14 Hz, 1 H, CHaHbNH), 3.71 (s, 3 H, OCH3), 2.83 (s, exch., 1 
H, OH), 1.85 (m, 1 H, CHcHdCOH), 1.74 (m, 1 H, CHcHdCOH), 1.55 (s, 3 H, CH3COH), 1.25–
1.11 (m, 4 H, CH2CH2CH3), 1.05 [s, 9 H, C(CH3)3], 0.78 (app. t, J = 7 Hz, 3 H, CH3CH2). 13C 
NMR (100 MHz, CDCl3): δ = 178.3 (C=O), 158.7 (C-4), 146.9 (C-2), 134.1 (C-6), 129.5 (C-1), 
114.1 (C-3), 111.3 (C-5), 77.0 (C-OH), 55.6 (OCH3), 44.7 (CH2CH2CH2CH3), 42.9 (CH2NH), 
38.9 [C(CH3)3], 31.5 (CH3COH), 27.9 [C(CH3)3], 26.9 (CH2CH2CH3), 23.5 (CH2CH3), 14.4 
(CH2CH3). HRMS (CI): m/z calcd for C19H32NO3 [MH]+: 322.2377; found: 322.2379.  
N-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methoxybenzyl)pivalamide (30). 0.58 g (1.64 
mmol, 82%). Mp 130–132 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.76 (app. t, J = 6 Hz, exch., 
1 H, NH), 7.22 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.08 (d, J = 2 Hz, 1 H, H-3), 
7.07 (d, J = 8 Hz, 1 H, H-6), 6.88 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 6.80 (dd, J = 
2, 8 Hz, 1 H, H-5), 5.86 (s, 1 H, CH), 5.81 (s, exch., 1 H, OH), 4.26 (dd, J = 6, 15 Hz, 1 H, 
CHaCHb), 3.98 (dd, J = 6, 15 Hz, 1 H, CHaHb), 3.74 (s, 3 H, OCH3), 3.73 (s, 3 H, OCH3), 1.11 [s, 
9 H, C(CH3)3]. 13C NMR (100 MHz, DMSO-d6): δ = 177.5 (C=O), 158.5 (C-4), 158.4 (C-4 of 
4-methoxyphenyl), 144.3 (C-2), 136.6 (C-1 of 4-methoxyphenyl), 136.5 (C-1), 128.7 (C-6), 
128.6 (C-2/C-6 of 4-methoxyphenyl), 113.8 (C-3/C-5 of 4-methoxyphenyl), 112.8 (C-3), 111.9 
(C-5), 70.8 (CH), 55.4 (OCH3), 55.3 (OCH3), 39.2 [C(CH3)3], 39.4 (CH2), 27.8 [C(CH3)3]. 
HRMS (ES+): m/z calcd for C21H27NO4Na [M + Na]+: 380.1832; found: 380.1832. Anal. Calcd 
for C21H27NO4: C, 70.56; H, 7.61; N, 3.92. Found: C, 70.63; H, 7.64; N, 3.89. 
N-(2-Deuterio-4-methoxybenzyl)pivalamide (31). 0.39 g (1.76 mmol, 88%). Mp 90–91 °C 
(Mp of undeuteriated analogue 88–90 °C17). 1H NMR (400 MHz, CDCl3): δ = 7.18 (d, J = 8 Hz, 
1 H, H-6), 6.88–6.76 (m, 2 H, H-3 and H-5), 5.96 (br t, exch., 1 H, NH), 4.34 (d, J = 6 Hz, 2 H, 
CH2), 3.79 (s, 3 H, OCH3), 1.21 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.6 
(C=O), 159.3 (C-4), 131.1 (C-1), 129.4 (C-6), 129.1 (seen as three lines, 1:1:1, because of 
coupling to D, C-2), 114.5 (C-3), 114.4 (C-5), 55.7 (OCH3), 43.4 (CH2), 39.1 [C(CH3)3], 28.0 
[C(CH3)3]. HRMS (CI): m/z calcd for C13H19DNO2 [MH]+: 223.1551; found: 223.1553.  
N-(4-Chloro-2-(hydroxy-(4-methoxyphenyl)methyl)benzyl)pivalamide (32). 0.60 g (1.66 
mmol, 83%). Mp 212–214 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.93 (br, exch., 1 H, NH), 
7.50 (s, 1 H, H-3), 7.30 (d, J = 8 Hz, 1 H, H-5), 7.20 (d, 2 H, J = 9 Hz, H-2/H-6 of 
4-methoxyphenyl), 7.12 (d, J = 8 Hz, 1 H, H-6), 6.88 (d, J = 9 Hz, 2 H, H-3/H-5 of 
4-methoxyphenyl), 5.93 (d, J = 3 Hz, exch., 1 H, OH), 5.89 (d, J = 3 Hz, 1 H, CH), 4.30 (dd, J = 
6, 14 Hz, 1 H, CHaHb), 3.95 (dd, J = 6, 14 Hz, 1 H, CHaHb), 3.70 (s, 3 H, OCH3), 1.10 [s, 9H, 
C(CH3)3]. 13C NMR (125 MHz, DMSO-d6): δ = 177.9 (C=O), 158.8 (C-4 of 4-methoxyphenyl), 
145.3 (C-1), 136.0 (C-1 of 4-methoxyphenyl), 135.8 (C-2), 131.6 (C-4), 129.0 (C-6), 128.8 (C-
2/C-6 of 4-methoxyphenyl), 127.0 (C-3), 126.5 (C-5), 114.1 (C-3/C-5 of 4-methoxyphenyl), 70.4 
(CH), 55.5 (OCH3), 40.0 [C(CH3)3], 38.5 (CH2), 27.9 [C(CH3)3]. HRMS (EI): m/z calcd for 
C20H24NO335Cl [M]+: 361.1445; found: 361.1447. 
N-(4-Chloro-2-(hydroxyphenylmethylbenzyl)pivalamide (33). 0.54 g (1.63 mmol, 82%). Mp 
180–182 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.90 (app. t, J = 6 Hz, exch., 1 H, NH), 7.85-
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7.70 (m, 5 H, Ph), 7.70 (s, 1 H, H-3), 7.67 (d, J = 8 Hz, 1 H, H-5), 7.62 (d, J = 8 Hz, 1 H, H-6), 
6.60 (s, exch., 1 H, OH), 5.85 (s, 1 H, CH), 4.90 (dd, J = 6, 14 Hz, 1 H, CHaHb), 4.65 (dd, J = 6, 
14 Hz, 1 H, CHaHb), 1.50 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, DMSO-d6): δ = 177.9 (C=O), 
158.8 (C-2), 145.3 (C-1), 136.0 (C-4), 135.8 (C-1 of Ph), 130.7 (C-4 of Ph), 128.7 (C-3/C-5 of 
Ph), 127.7 (C-6), 127.6 (C-5), 127.5 (C-3), 127.4 (C-2/C-6 of Ph), 72.1 (CH), 39.9 (CH2), 38.7 
[C(CH3)3], 27.4 [C(CH3)3]. HRMS (EI): m/z calcd for C19H22NO235Cl [M]+: 331.1339; found: 
331.1345.  
N-(4-Chloro-2-(hydroxydiphenylmethyl)benzyl)pivalamide (34). 0.64 g (1.57 mmol, 79%). 
Mp 240–242 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.83 (br, exch., 1 H, NH), 7.38-7.36 (m, 
10 H, 2 Ph), 7.30 (d, J = 8 Hz, 1 H, H-5), 7.20 (d, J = 8 Hz, 1 H, H-6), 7.10 (s, exch., 1 H, OH), 
6.50 (s, 1 H, H-3), 3.90 (d, J = 6 Hz, 2 H, CH2), 1.07 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, 
DMSO-d6): δ = 178.2 (C=O), 147.3 (C-1 of 2 Ph), 147.2 (C-2), 138.9 (C-1), 132.3 (C-4), 130.6 
(C-6), 128.9 (C-3), 128.4 (C-3/C-5 of 2 Ph), 127.8 (C-2/C-6 of 2 Ph), 127.5 (C-4 of 2 Ph), 127.5 
(C-5), 81.6 (C-OH), 41.0 (CH2), 38.4 [C(CH3)3], 27.8 [C(CH3)3]. HRMS (APCI): m/z calcd for 
C25H26NO235ClK [M + K]+: 446.1289; found: 446.1304.  
N-(4-Chloro-2-(1-hydroxycyclohexyl)benzyl)pivalamide (35). 0.47 g (1.45 mmol, 73%). Mp 
166–168 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.91 (s, 1 H, H-3), 7.83 (t, J = 6 Hz, 1 H, NH), 
7.80 (d, J = 8 Hz, 1 H, H-5), 7.63 (d, J = 8 Hz, 1 H, H-6), 5.22 (s, exch., 1 H, OH), 5.20 (d, J = 6 
Hz, 2 H, CH2N), 2.40–2.05 [m, 10 H, (CH2)5], 1. 60 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, 
DMSO-d6): δ = 177.8 (C=O), 150.2 (C-2), 138.4 (C-1), 132.4 (C-4), 132.4 (C-6), 126.8 (C-3), 
126.0 (C-5), 73.9 (C-OH), 41.7 (CH2NH), 38.8 (C-2/C-6 of cyclohexyl), 29.7 [C(CH3)3], 27.4 
[C(CH3)3], 25.8 (C-4 of cyclohexyl), 22.2 (C-3/C-5 of cyclohexyl). HRMS (EI): m/z calcd for 
C18H26NO235Cl [M]+: 323.1652; found: 323.1656.  
N-(4-Chloro-2-ethylbenzyl)pivalamide (36). 0.40 g (1.58 mmol, 79%). Mp 117–119 ºC. 1H 
NMR (500 MHz, CDCl3): δ = 7.30 (s, 1 H, H-3), 7.20 (d, J = 8 Hz, 1 H, H-5), 7.15 (d, J = 8 Hz, 
1 H, H-6), 5.80 (br, exch., 1 H, NH), 4.40 (d, J = 6 Hz, 2 H, CH2N), 2.65 (q, J = 7 Hz, 2 H, 
CH2CH3), 1.20 (t, J = 7 Hz, 3 H, CH2CH3), 1.20 [s, 9 H, C(CH3)3]. 13C NMR (125 MHZ, 
CDCl3): δ = 178.1 (C=O), 144.3 (C-2), 134.1 (C-1), 133.5 (C-4), 130.0 (C-6), 128.7 (C-3), 126.2 
(C-5), 40.7 (CH2NH), 38.7 [C(CH3)3], 27.6 [C(CH3)3], 25.2 (CH2CH3), 15.5 (CH2CH3). HRMS 
(EI): m/z calcd for C14H20NO35Cl [M]+: 253.1233; found: 253.1234.  
N-(4-Chloro-2-deuteriobenzyl)pivalamide (37). 0.40 g (1.76 mmol, 88%). Mp 114–116 ºC 
(Mp of undeuteriated analogue 114–116 °C10). 1H NMR (500 MHz, CDCl3): δ = 7.30 (d, J = 8 
Hz, 1 H, H-5), 7.20 (s, 1 H, H-3), 7.18 (d, J = 8 Hz, 1 H, H-6), 6.09 (br t, exch., 1 H, NH), 4.40 
(d, J = 6 Hz, 2 H, CH2), 1.22 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, CDCl3): δ = 178.4 (C=O), 
137.2 (C-1), 133.1 (C-4), 128.9 (C-3), 128.8 (C-5), 128.7 (C-6), 128.6 (seen as three lines, 1:1:1, 
because of coupling to D, C-2), 42.8 (CH2), 38.7 [C(CH3)3], 27.6 [C(CH3)3]. HRMS (APCI): m/z 
calcd for C12H16DNO35Cl [MH]+: 227.1061; found: 227.1059.  
N-(4-Fluoro-2-(hydroxy-(4-methoxyphenyl)methyl)benzyl)pivalamide (38). 0.54 g (1.56 
mmol, 78%). Mp 200–202 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.93 (app. t, J = 6 Hz, exch., 
1 H, NH), 7.30 (m, 1 H, H-6), 7.20 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.12 (m, 1 
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H, H-5), 7.05 (m, 1 H, H-3), 6.89 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 5.93 (s, 
exch., 1 H, OH), 5.89 (s, 1 H, CH), 4.30 (dd, J = 6, 14 Hz, 1 H, CHaHb), 3.95 (dd, J = 6, 14 Hz, 1 
H, CHaHb), 3.71 (s, 3 H, OCH3), 1.10 [s, 9H, C(CH3)3]. 13C NMR (125 MHz, DMSO-d6): δ = 
177.8 (C=O), 161.6 (seen as two lines because of coupling to F, J = 241 Hz, C-4), 158.8 (C-4 of 
4-methoxyphenyl), 145.7 (seen as two lines because of coupling to F, J = 8 Hz, C-2), 136.2 (C-1 
of 4-methoxyphenyl), 132.7 (seen as two lines because of coupling to F, J = 2 Hz, C-1), 129.1 
(seen as two lines because of coupling to F, J = 8 Hz, C-6), 128.8 (C-2/C-6 of 
4-methoxyphenyl), 114.0 (C-3/C-5 of 4-methoxyphenyl), 113.6 (seen as two lines because of 
coupling to F, J = 21 Hz, C-3), 113.3 (seen as two lines because of coupling to F, J = 21 Hz, C-
5), 70.4 (CH), 55.5 (OCH3), 40.0 [C(CH3)3], 38.5 (CH2), 27.9 [C(CH3)3]. HRMS (ES+): m/z 
calcd for C20H25NO3F [MH]+: 346.1818; found: 346.1830.  
N-(4-Fluoro-2-(hydroxyphenylmethylbenzyl)pivalamide (39). 0.50 g (1.58 mmol, 79%). Mp 
157–159 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.93 (app. t, J = 6 Hz, exch., 1H, NH), 7.32-
7.23 (m, 6 H, Ph and H-6), 7.15 (m, 1 H, H-5), 7.05 (m, 1 H, H-3), 6.05 (s, exch., 1 H, OH), 5.95 
(s, 1 H, CH), 4.30 (dd, J = 6, 14 Hz, 1 H, CHaHb), 4.02 (dd, J = 6, 14 Hz, 1 H, CHaHb), 1.10 [s, 9 
H, C(CH3)3]. 13C NMR (125 MHz, DMSO-d6): δ = 161.6 (seen as two lines because of coupling 
to F, J = 241 Hz, C-4), 158.5 (C=O), 145.4 (seen as two lines because of coupling to F, J = 8 Hz, 
C-2), 144.1 (C-1 of Ph), 132.9 (seen as two lines because of coupling to F, J = 3 Hz, C-1), 132.9 
(C-4 of Ph), 129.3 (seen as two lines because of coupling to F, J = 8 Hz, C-6), 128.6 (C-3/C-5 of 
Ph), 127.5 (C-2/C-6 of Ph), 113.8 (seen as two lines because of coupling to F, J = 22 Hz, C-3), 
113.6 (seen as two lines because of coupling to F, J = 22 Hz, C-5), 70.8 (CH), 40.0 [C(CH3)3], 
38.5 (CH2), 27.9 [C(CH3)3]. HRMS (ES+): m/z calcd for C19H23NO2F [MH]+: 316.1713; found: 
316.1715.  
N-(4-Fluoro-2-(hydroxydiphenylmethyl)benzyl)pivalamide (40). 0.60 g (1.53 mmol, 76%). 
Mp 216–218 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.85 (t, J = 6 Hz, exch., 1 H, NH), 7.29-
7.22 (m, 11 H, 2 Ph and H-6), 7.13-710 (m, 2 H, H-3 and H-5), 6.22 (s, exch., 1 H, OH), 4.95 (d, 
J = 6 Hz, 2 H, CH2), 1.10 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, DMSO-d6): δ = 178.1 (C=O), 
160.3 (seen as two lines because of coupling to F, J = 240 Hz, C-4), 147.4 (seen as two lines 
because of coupling to F, J = 7 Hz, C-2), 135.8 (C-1 of 2 Ph), 132.9 (seen as two lines because of 
coupling to F, J = 3 Hz, C-1), 130.8 (seen as two lines because of coupling to F, J = 7 Hz, C-6), 
128.4 (C-3/C-5 of 2 Ph), 127.8 (C-2/C-6 of 2 Ph), 127.5 (C-4 of 2 Ph), 116.1 (seen as two lines 
because of coupling to F, J = 22 Hz, C-3), 114.4 (seen as two lines because of coupling to F, J = 
22 Hz, C-5), 81.6 (C-OH), 40.2 (CH2), 38.4 [C(CH3)3], 27.8 [C(CH3)3]. HRMS (CI): m/z calcd 
for C25H25NOF [MH – H2O]+: 374.1920; found: 374.1925.  
N-(4-Fluoro-2-(1-hydroxycyclohexylbenzyl)pivalamide (41). 0.50 g (1.63 mmol, 82%). Mp 
140–142 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.88 (br, exch., 1 H, NH), 7.22-6.98 (m, 3 H, 
H-3, H-5 and H-6), 5.0 (s, exch., 1 H, OH), 4.55 (d, J = 6 Hz, 2 H, CH2N), 1.93–1.50 [m, 10 H, 
(CH2)5], 1.10 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, DMSO-d6): δ = 177.8 (C=O), 162.2 (seen 
as two lines because of coupling to F, J = 240 Hz, C-4), 150.4 (seen as two lines because of 
coupling to F, J = 8 Hz, C-2), 134.8 (seen as two lines because of coupling to F, J = 2 Hz, C-1), 
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129.9 (seen as two lines because of coupling to F, J = 8 Hz, C-6), 113.1 (seen as two lines 
because of coupling to F, J = 20 Hz, C-3), 112.5 (seen as two lines because of coupling to F, J = 
20 Hz, C-5), 73.0 (C-OH), 41.2 (CH2NH), 38.5 [C(CH3)3], 37.7 (C-2/C-6 of cyclohexyl), 27.9 
[C(CH3)3], 25.6 (C-4 of cyclohexyl), 22.3 (C-3/C-5 of cyclohexyl). HRMS (ES+): m/z calcd for 
C18H27NO2F [MH]+: 308.2026; found: 308.2039.  
N-(4-Fluoro-2-ethylbenzyl)pivalamide (42). 0.39 g (1.64 mmol, 82%). Oil. 1H NMR (500 
MHz, CDCl3): δ = 7.05 (m, 1 H, H-6), 6.72-6.61 (m, 2 H, H-3 and H-5), 6.49 (br, exch., 1 H, 
NH), 4.20 (d, J = 6 Hz, 2 H, CH2N), 2.49 (q, J = 7 Hz, 2 H, CH2CH3), 1.10 (t, J = 7 Hz, 3 H, 
CH2CH3), 1.10 [s, 9 H, C(CH3)3]. 13C NMR (125 MHz, CDCl3): δ = 178.3 (C=O), 162.1 (seen as 
two lines because of coupling to F, J = 246 Hz, C-4), 144.3 (seen as two lines because of 
coupling to F, J = 7 Hz, C-2), 131.6 (seen as two lines because of coupling to F, J = 2 Hz, C-1), 
129.6 (seen as two lines because of coupling to F, J = 7 Hz, C-6), 114.9 (seen as two lines 
because of coupling to F, J = 21 Hz, C-3), 112.4 (seen as two lines because of coupling to F, J = 
21 Hz, C-5), 40.3 (CH2N), 38.5 [C(CH3)3], 27.4 [C(CH3)3], 25.1 (CH2), 14.6 (CH3). HRMS (EI): 
m/z calcd for C14H20NOF [M]+: 237.1529; found: 237.1522.  
N-(2-Deuterio-4-fluorobenzyl)pivalamide (43). 0.36 g (1.71 mmol, 85%). Mp 97–99 ºC (Mp of 
undeuteriated analogue 97–99 °C10). 1H NMR (500 MHz, CDCl3): δ = 7.12 (m, 1 H, H-6), 6.93-
6.89 (m, 2 H, H-3 and H-5), 6.10 (br, exch., 1 H, NH), 4.29 (d, J = 6 Hz, 2 H, CH2), 1.15 [s, 9 H, 
C(CH3)3]. 13C NMR (125 MHz, CDCl3): δ = 178.4 (C=O), 162.1 (seen as two lines because of 
coupling to F, J = 244 Hz, C-4), 134.5 (seen as two lines because of coupling to F, J = 3 Hz, C-
1), 129.2 (seen as two lines because of coupling to F, J = 8 Hz, C-6), 128.9 (seen as six lines, 
because of coupling to F and D, J = 8, 25 Hz, C-2), 115.5 (seen as two lines because of coupling 
to F, J = 12 Hz, C-3), 115.3 (seen as two lines because of coupling to F, J = 12 Hz, C-5), 42.7 
(CH2), 38.7 [C(CH3)3], 27.6 [C(CH3)3]. HRMS (ES+): m/z calcd for C12H15DNOF [M]+: 
210.1279; found: 210.1279.  
N-(2,4-Dimethylbenzyl)-N-methylpivalamide (44). The procedure was identical with the 
general one except that excess iodomethane (0.63 g, 4.4 mmol) was used as an electrophile. The 
reaction mixture was worked-up and purified by column chromatography (silica gel; Et2O–
hexane, 1:3) to give 44 as a colourless oil. 0.41 g (1.76 mmol, 88%). 1H NMR (400 MHz, 
CDCl3): δ = 7.04–6.85 (m, 3 H, H-3, H-5 and H-6), 4.49 (s, 2 H, CH2), 2.86 (s, 3 H, NCH3), 2.18 
(s, 3 H, CH3), 2.12 (s, 3 H, CH3), 1.21 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 
178.0 (C=O), 137.0 (C-2), 136.2 (C-4), 133.5 (C-1), 131.6 (C-3), 129.7 (C-6), 127.1 (C-5), 51.1 
(CH2), 39.4 (NCH3), 36.6 [C(CH3)3], 28.8 [C(CH3)3], 21.3 (CH3), 19.3 (CH3). HRMS (CI): m/z 
calcd for C15H24NO [MH]+: 234.1852; found: 234.1853.  
N-(4-Methoxy-2-methylbenzyl)-N-methylpivalamide (45). The procedure was identical with 
the general one except that excess iodomethane (0.63 g, 4.4 mmol) was used. The reaction 
mixture was worked-up and purified by column chromatography (silica gel; Et2O–hexane, 1:3) 
to give 45 (0.43 g, 1.74 mmol, 87%) as a colourless oil. 1H NMR (400 MHz, CDCl3): δ = 6.87 
(d, J = 8 Hz, 1 H, H-6), 6.61-6.59 (m, 2 H, H-3 and H-5), 4.47 (s, 2 H, CH2), 3.66 (s, 3 H, 
OCH3), 2.85 (s, 3 H, NCH3), 2.14 (s, 3 H, CH3), 1.21 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, 
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CDCl3): δ = 178.9 (C=O), 159.0 (C-4), 137.8 (C-2), 128.8 (C-1), 127.6 (C-6), 116.6 (C-3), 111.4 
(C-5), 55.6 (OCH3), 50.7 (CH2), 39.5 [C(CH3)3], 36.4 (NCH3), 28.8 [C(CH3)3], 19.6 (CH3). 
HRMS (CI): m/z calcd for C15H24NO2 [MH]+: 250.1802; found: 250.1804.  
2-Methoxy-3-(pivaloylaminomethyl)benzoic acid (47). In this case, after formation of the 
dianion at low temperature, the cooling bath was removed before solid carbon dioxide was added 
and the mixture was then stirred for 30 minutes while the temperature rose to room temperature 
and then quenched with HCl (2 M; 5 mL). The crude product was purified by fractional 
crystallisation using ethyl acetate. 0.42 g (1.59 mmol, 80%). Mp 156–157 °C. 1H NMR (500 
MHz, DMSO-d6): δ = 8.03 (t, J = 6 Hz, exch., 1 H, NH), 7.57 (dd, J = 2, 8 Hz, 1 H, H-6), 7.32 
(dd, J = 2, 8 Hz, 1 H, H-4), 7.16 (app. t, J = 8 Hz, 1 H, H-5), 4.32 (d, J = 6 Hz, 2 H, CH2), 3.79 
(s, 3 H, OCH3), 1.15 [s, 9 H, C(CH3)3] (the CO2H signal was not seen due to exchange with 
water in the DMSO). 13C NMR (125 MHz, DMSO-d6): δ = 178.1 (C=O), 167.8 (CO2H), 157.1 
(C-2), 134.6 (C-3), 131.5 (C-4), 129.6 (C-6), 126.1 (C-1), 123.9 (C-5), 62.1 (OCH3), 38.6 
[C(CH3)3], 37.3 (CH2), 27.9 [C(CH3)3]. HRMS (ES+): m/z calcd for C14H20NO4 [MH]+: 
266.1392; found: 266.1386.  
N-(3-(Hydroxy(4-methoxyphenyl)methyl)-2-methoxybenzyl)pivalamide (48). 0.54 g (1.52 
mmol; 76%). Mp 144–145 °C. 1H NMR (400 MHz, DMSO-d6): δ = 8.04 (app. t, J = 6 Hz, exch., 
1 H, NH), 7.39 (dd, J = 2, 8 Hz, 1 H, H-4), 7.28 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 
7.13 (app. t, J = 8 Hz, 1 H, H-5), 7.08 (dd, J = 2, 8 Hz, 1 H, H-6), 6.89 (d, J = 9 Hz, 2 H, H-3/H-
5 of 4-methoxyphenyl), 5.98 (d, J = 4 Hz, exch., 1 H, OH), 5.72 (d, J = 4 Hz, 1 H, CH), 4.40 (dd, 
J = 6, 16 Hz, 1 H, CHaHb), 4.28 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.75 (s, 3 H, OCH3), 3.72 (s, 3 
H, OCH3), 1.19 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, DMSO-d6): δ = 178.4 (C=O), 158.9 (C-
2), 154.9 (C-4 of 4-methoxyphenyl), 139.4 (C-1 of 4-methoxyphenyl), 138.3 (C-1), 133.5 (C-3), 
128.5 (C-2/C-6 of 4-methoxyphenyl), 127.0 (C-4), 126.8 (C-6), 124.7 (C-5) 114.1 (C-3/C-5 of 
4-methoxyphenyl), 68.7 (CH), 61.9 (OCH3), 55.9 (OCH3), 38.9 [C(CH3)3], 37.5 (CH2), 28.3 
[C(CH3)3]. HRMS (CI): m/z calcd for C21H28NO4 [MH]+: 358.2013; found: 358.2014. Anal. 
Calcd for C21H27NO4: C, 70.56; H, 7.61; N, 3.92. Found: C, 70.56; H, 7.64; N, 4.09. 
N-(3-(Hydroxyphenylmethyl)-2-methoxybenzyl)pivalamide (49). 0.49 g (1.50 mmol, 75%). 
Mp 133–135 °C. 1H NMR (400 MHz, CDCl3): δ = 7.41 (d, J = 7 Hz, 2 H, H-3/H-5 of Ph), 7.36–
7.32 (m, 3 H, H-2/H-4/H-6 of Ph), 7.27 (dd, J = 2, 8 Hz, 1 H, H-4), 7.19 (dd, J = 2, 8 Hz, 1 H, H-
6), 7.13 (app. t, J = 8 Hz, 1 H, H-5), 6.12 (br app. t, exch., 1 H, NH), 6.10 (s, 1 H, CH), 4.51 (dd, 
J = 6, 15 Hz, 1 H, HaHb), 4.44 (dd, J = 5, 15 Hz, 1 H, CHaHb), 3.59 (s, 3 H, OCH3), 2.97 (br, 
exch., 1 H, OH), 1.21 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.9 (C=O), 156.1 
(C-2), 144.1 (C-1 of Ph), 137.8 (C-1), 132.0 (C-3), 129.2 (C-4), 128.8 (C-3/C-5 of Ph), 128.1 (C-
4 of Ph), 127.8 (C-6), 126.9 (C-2/C-6 of Ph), 125.2 (C-5), 71.8 (CH), 62.1 (OCH3), 39.1 (CH2), 
39.0 [C(CH3)3], 28.0 [C(CH3)3]. HRMS (ES+): m/z calcd for C20H26NO3 [MH]+: 328.1907; 
found: 328.1905. Anal. Calcd for C20H25NO3: C, 73.37; H, 7.70; N, 4.28. Found: C, 73.39; H, 
7.72; N, 4.26. 
N-(3-(Hydroxydiphenylmethyl)-2-methoxybenzyl)pivalamide (50). 0.59 g (1.46 mmol, 73%). 
Mp: 173–174 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.80 (t, J = 6 Hz, exch., 1 H, NH), 7.10–
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7.01 (m, 10 H, 2 Ph), 6.90 (d, J = 8 Hz, 1 H, H-4), 6.76 (app. t, J = 8 Hz, 1 H, H-5), 6.48 (dd, J = 
2, 8 Hz, 1 H, H-6), 5.74 (s, exch., 1 H, OH), 4.04 (d, J = 6 Hz, 2 H, CH2), 3.12 (s, 3 H, OCH3), 
0.92 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, DMSO-d6): δ = 178.5 (C=O), 156.4 (C-2), 147.9 
(C-1 of 2 Ph), 141.2 (C-1), 134.5 (C-3), 128.4 (C-2/C-6 and C-3/C-5 of 2 Ph), 128.4 (C-4), 128.3 
(C-6), 127.7 (C-4 of 2 Ph), 123.7 (C-5), 81.5 (C-OH), 61.2 (OCH3), 40.0 [C(CH3)3], 37.8 (CH2), 
28.3 [C(CH3)3]. HRMS (ES+): m/z calcd for C26H30NO3 [MH]+: 404.2220; found: 404.2219. 
N-(3-Deuterio-2-methoxybenzyl)pivalamide (51). 0.38 g (1.72 mmol, 86%). Mp: 103–104 °C 
(Mp of undeuteriated analogue, 103–104 °C10). 1H NMR (400 MHz, CDCl3): δ = 7.21–7.15 (m, 
2 H, H-5 and H-6), 6.83 (m, 1 H, H-4), 6.14 (br, exch., 1 H, NH), 4.36 (d, J = 6 Hz, 2 H, CH2), 
3.78 (s, 3 H, OCH3), 1.11 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, CDCl3): δ = 178.4 (C=O), 
158.0 (C-2), 130.1 (C-6), 129.1 (C-4), 129.0 (C-1), 121.1 (C-5), 110.5 (seen as three lines, 1:1:1, 
because of coupling to D, C-3), 55.7 (OCH3), 40.0 (CH2), 39.1 [C(CH3)3], 28.0 [C(CH3)3]. 
HRMS (CI): m/z calcd for C13H19DNO2 [MH]+: 223.1551; found: 223.1550. 
N-(2-Hydroxy-1-(2-methoxyphenyl)-2-(4-methoxyphenyl)ethyl)pivalamide (53). 14 mg (0.04 
mmol, 2%). Mp 203–205 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.25 (d, J = 9 Hz, 2 H, H-
2/H-6 of 4-methoxyphenyl), 7.23–7.19 (m, 3 H, NH, H-4 and H-6), 6.96 (d, J = 8 Hz, 1 H, H-3), 
6.91 (app. t, J = 8 Hz, 1 H, H-5), 6.86 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 5.52 (d, J 
= 4 Hz, exch., 1 H, OH), 5.24 (dd, J = 3, 6 Hz, 1 H, CHNH), 4.78 (dd, J = 4, 3 Hz, 1 H, CHOH), 
3.83 (s, 3 H, OCH3), 3.72 (s, 3 H, OCH3), 1.05 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, DMSO-
d6): δ = 176.5 (C=O), 158.4 (C-4 of 4-methoxyphenyl), 156.5 (s, C-2), 136.2 (s, C-1 of 
4-methoxyphenyl), 130.3 (s, C-1), 128.1 (C-6), 127.6 (C-4), 127.2 (C-2/C-6 of 
4-methoxyphenyl), 120.3 (C-5), 113.3 (C-3/C-5 of 4-methoxyphenyl), 110.9 (C-3), 73.1 
(CHOH), 55.8 (OCH3), 55.3 (OCH3), 53.8 (CHNH), 38.5 [C(CH3)3], 27.6 [C(CH3)3]. HRMS 
(CI): m/z calcd for C21H28NO4 [MH]+: 358.2013; found: 358.2012. 
N-(2-Hydroxy-1-(2-methoxyphenyl)-2,2-diphenylethyl)pivalamide (54). 24 mg (0.06 mmol, 
3%). Mp: 203–204 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.54–6.99 (m, 13 H, 2 Ph, H-4, H-6 
and NH), 6.86 (app. t, J = 8 Hz, 1 H, H-5), 6.54 (d, J = 8 Hz, 1 H, H-3), 6.34 (d, J = 9 Hz, 1 H, 
CH), 6.15 (s, exch., 1 H, OH), 3.14 (s, 3 H, OCH3), 0.91 [s, 9 H, C(CH3)3]. 13C NMR (100 MHz, 
DMSO-d6): δ = 176.6 (C=O), 157.0 (C-2), 147.5, 145.3 (C-1 of 2 Ph), 130.8 (C-6), 128.9 (C-1), 
128.52, 128.49 (C-3/C-5 of 2 Ph), 127.51, 127.41 (C-2/C-6 of 2 Ph), 127.4, 127.1 (C-4 of 2 Ph), 
126.6 (C-4), 120.1 (C-5), 110.4 (C-3), 80.9 (C-OH), 55.4 (OCH3), 52.1 (CH), 38.7 [C(CH3)3], 
27.9 [C(CH3)3]. HRMS (CI): m/z calcd for C26H30NO3 [MH]+: 404.2220; found: 404.2221. 
3-Methoxy-2-(pivaloylaminomethyl)benzoic acid (55). The procedure used for isolation of 55 
was different than the general procedure. A solution of sec-BuLi in cyclohexane (3.2 mL, 1.4 M, 
4.4 mmol) was added to a cold (0 °C), stirred solution of 46 (0.44 g, 2.0 mmol) in anhydrous 
THF (20 mL) under N2. The brownish solution obtained was stirred at 0 °C for 2 h, after which 
the cooling bath was removed. Solid carbon dioxide was added and the mixture was stirred for 
30 minutes while the mixture was allowed to warm to room temperature. It was then diluted with 
ethyl acetate (10 mL) and quenched with HCl (2 M; 5 mL). The organic layer was separated, 
washed with H2O (2 x 10 mL), dried (MgSO4), and evaporated under reduced pressure. The 
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residue obtained was treated with diethyl ether and on standing overnight gave 55 (0.13 g, 0.49 
mmol, 25%) as white crystals. Mp 170-171 °C (lit.8 168–169 °C). 1H NMR (500 MHz, DMSO-
d6): δ = 7.43 (t, J = 6 Hz, exch., 1 H, NH), 7.34 (app. t, J = 8 Hz, 1 H, H-5), 7.27 (dd, J = 2, 8 
Hz, 1 H, H-6), 7.19 (br d, J = 8 Hz, 1 H, H-4), 4.47 (d, J = 6 Hz, 2 H, CH2), 3.82 (s, 3 H, OCH3), 
1.05 [s, 9 H, C(CH3)3] (the CO2H signal was not seen due to exchange with water in the DMSO). 
13C NMR (125 MHz, DMSO-d6): δ = 177.5 (C=O), 169.7 (CO2H), 158.4 (C-3), 134.3 (C-2), 
128.7 (C-5), 126.7 (C-1), 121.6 (C-6), 114.6 (C-4), 56.5 (OCH3), 38.4 [C(CH3)3], 35.7 (CH2), 
27.8 [C(CH3)3]. HRMS (ES+): m/z calcd for C14H20NO4 [MH]+: 266.1392; found: 266.1392. 
N'-(2-(Hydroxy-(4-methoxyphenyl)methyl)benzyl)-N,N-dimethylurea (61). 0.54 g (1.72 
mmol, 86%). Mp 185–186 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.44 (app. dt, J = 2, 8 Hz, 1 
H, H-4), 7.27-7.21 (m, 5 H, H-3, H-5, H-6 and H-2/H-6 of 4-methoxyphenyl), 6.87 (d, J = 9 Hz, 
2 H, H-3/H-5 of 4-methoxyphenyl), 6.66 (t, J = 6 Hz, exch., 1 H, NH), 5.92 (d, J = 4 Hz, 1 H, 
CH), 5.80 (d, J = 4 Hz, exch., 1 H, OH), 4.30 (dd, J = 6, 16 Hz, 1 H, CHaHb), 4.09 (dd, J = 6, 16 
Hz, 1 H, CHaHb), 3.73 (s, 3 H, OCH3), 2.79 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, DMSO-d6): 
δ = 159.0 (C=O), 158.9 (C-4 of 4-methoxyphenyl), 143.3 (C-1), 138.3 (C-2), 137.4 (C-1 of 
4-methoxyphenyl), 129.0 (C-2/C-6 of 4-methoxyphenyl), 128.1 (C-3), 127.4 (C-6), 127.3 (C-4), 
127.1 (C-5) 114.2 (C-3/C-5 of 4-methoxyphenyl), 71.2 (CH), 55.9 (OCH3), 44.4 (CH2), 36.7 
[N(CH3)2]. HRMS (ES+): m/z calcd for C18H23N2O3 [MH]+: 315.1703; found: 315.1700. Anal. 
Calcd for C18H22N2O3: C, 68.77; H, 7.05; N, 8.91. Found: C, 68.55; H, 7.14; N, 8.84. 
N'-(2-(Hydroxyphenylmethyl)benzyl)-N,N-dimethylurea (62). 0.47 g (1.65 mmol, 82%). Mp 
138–140 °C. 1H NMR (400 MHz, CDCl3): δ = 7.37-7.23 (m, 9 H, ArH), 6.05 (d, J = 4 Hz, 1 H, 
CH), 5.00 (t, J = 6 Hz, exch., 1 H, NH), 4.71 (d, J = 4 Hz, exch., 1 H, OH), 4.38 (dd, J = 6, 14 
Hz, 1 H, CHaHb), 4.27 (dd, J = 6, 14 Hz, 1 H, CHaHb), 2.71 [s, 6 H, N(CH3)2]. 13C NMR (100 
MHz, CDCl3): δ = 158.7 (C=O), 144.1 (C-1 of Ph), 142.2 (C-1), 137.8 (C-2), 130.6 (C-3), 128.9 
(C-6), 128.7 (C-3/C-5 of Ph), 128.4 (C-4), 128.0 (C-5), 127.6 (C-4 of Ph), 127.1 (C-2/C-6 of Ph), 
73.8 (CH), 42.6 (CH2), 36.4 [N(CH3)2]. HRMS (ES+): m/z calcd for C17H21N2O2 [MH]+: 
285.1598; found: 285.1600. 
N'-(2-(Hydroxydiphenylmethyl)benzyl)-N,N-dimethylurea (63). 0.61 g (1.69 mmol, 84%). 
Mp 235–236 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.43-7.23 (m, 13 H, 2 Ph, H-4, H-6 and 
OH), 7.04 (dt, J = 2, 8 Hz, 1 H, H-5), 6.80 (t, J = 6 Hz, exch., 1 H, NH), 6.49 (dd, J = 2, 8 Hz, 1 
H, H-3), 3.86 (d, J = 6 Hz, 2 H, CH2), 2.76 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, DMSO-d6): 
δ = 159.3 (C=O), 149.0 (C-1 of 2 Ph), 145.3 (C-1), 141.2 (C-2), 130.5 (C-3), 129.5 (C-6), 128.9 
(C-3/C-5 of 2 Ph), 128.6 (C-5), 128.4 (C-2/C-6 of 2 Ph), 127.4 (C-4 of 2 Ph), 126.3 (C-4), 82.0 
(C-OH), 43.0 (CH2), 36.7 [N(CH3)2]. HRMS (ES+): m/z calcd for C23H24N2O2Na [M + Na]+: 
383.1730; found: 383.1731. 
N'-(2-Methylbenzyl)-N,N-dimethylurea (64). 0.31 g (1.61 mmol, 80%). Mp 82–83 °C. 1H 
NMR (400 MHz, DMSO-d6): δ = 7.19–7.01 (m, 4 H, H-3, H-4, H-5 and H-6), 4.48 (br, exch., 1 
H, NH), 4.31 (br, 2 H, CH2), 2.82 [s, 6 H, N(CH3)2], 2.26 (s, 3 H, CH3). 13C NMR (100 MHz, 
DMSO-d6): δ = 158.7 (C=O), 137.5 (C-1), 136.8 (C-2), 130.8 (C-3), 128.8 (C-6), 127.9 (C-4), 
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126.5 (C-5), 43.6 (CH2), 36.7 [N(CH3)2], 19.45 (CH3). HRMS (CI): m/z calcd for C11H17N2O 
[MH]+: 193.1335; found: 193.1335. 
N'-(2-Deuteriobenzyl)-N,N-dimethylurea (65). 0.32 g (1.78 mmol, 89%). Mp 76–77 °C (Mp of 
undeuteriated analogue lit.18 77 °C). 1H NMR (400 MHz, CDCl3): δ = 7.35–7.24 (m, 4 H, H-3, 
H-4, H-5 and H-6), 4.84 (br, exch., 1 H, NH), 4.41 (br, 2 H, CH2), 2.91 [s, 6 H, N(CH3)2]. 13C 
NMR (100 MHz, CDCl3): δ = 158.8 (C=O), 140.2 (C-1), 128.9 (C-3), 128.8 (seen as three lines, 
1:1:1, because of coupling to D, C-2), 128.1 (C-5), 127.8 (C-6), 127.6 (C-4), 45.4 (CH2), 36.6 
[N(CH3)2]. HRMS (CI): m/z calcd for C10H14DN2O [MH]+: 180.1242; found: 180.1243. 
N'-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methylbenzyl)-N,N-dimethylurea (66). 0.50 g 
(1.52 mmol, 76%). Mp 174–175 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.26 (s, 1 H, H-3), 
7.21 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.11 (d, J = 8 Hz, 1 H, H-6), 7.01 (d, J = 8 
Hz, 1 H, H-5), 6.86 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 6.58 (t, J = 6 Hz, exch., 1 
H, NH), 5.89 (d, J = 5 Hz, 1 H, CH), 5.78 (d, J = 5 Hz, exch., 1 H, OH), 4.25 (dd, J = 6, 16 Hz, 1 
H, CHaHb), 4.03 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.72 (s, 3 H, OCH3), 2.78 [s, 6 H, N(CH3)2], 
2.58 (s, 3 H, CH3). 13C NMR (100 MHz, DMSO-d6): δ = 159.0 (C=O), 158.9 (s, C-4 of 4-
methoxyphenyl), 143.2 (C-2), 137.5 (C-1), 136.0 (C-4), 135.3 (C-1 of 4-methoxyphenyl), 128.9 
(C-2/C-6 of 4-methoxyphenyl), 128.5 (C-3), 128.0 (C-6), 127.8 (C-5) 114.2 (C-3/C-5 of 4-
methoxyphenyl), 71.2 (CH), 55.9 (OCH3), 41.4 (CH2), 36.7 [N(CH3)2], 21.8 (CH3). HRMS (CI): 
m/z calcd for C19H25N2O3 [MH]+: 329.1860; found: 329.1852. Anal. Calcd for C19H24N2O3: C, 
69.49; H, 7.37; N, 8.53. Found: C, 69.44; H, 7.40; N, 8.58. 
N'-(2-(Hydroxyphenylmethyl)-4-methylbenzyl)-N,N-dimethylurea (67). 0.41 g (1.39 mmol, 
70%). Mp 135–136 °C. 1H NMR (400 MHz, CDCl3): δ = 7.29–7.13 (m, 10 H, ArH, NH and 
OH), 5.97 (br s, 1 H, CH), 4.27 (d, J = 14 Hz, 1 H, CHaHb), 4.17 (d, J = 14 Hz, 1 H, CHaHb), 
2.64 [s, 6 H, N(CH3)2], 2.21 (s, 3 H, CH3). 13C NMR (100 MHz, CDCl3): δ = 158.7 (C=O), 144.2 
(C-1 of Ph), 142.2 (C-2), 138.5 (C-1), 134.7 (C-4), 130.8 (C-3), 129.6 (C-6), 129.1(C-5), 128.9 
(C-3/C-5 of Ph), 127.7 (C-4 of Ph), 127.1 (C-2/C-6 of Ph), 73.9 (CH), 42.4 (CH2), 36.5 
[N(CH3)2], 21.6 (CH3). HRMS (CI): m/z calcd for C18H23N2O2 [MH]+: 299.1754; found: 
299.1753. 
N'-(2-(Hydroxydiphenylmethyl)-4-methylbenzyl)-N,N-dimethylurea (68). 0.54 g (1.44 mmol, 
72%). Mp 225–227 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.40 (s, exch., 1 H, OH), 7.34–7.22 
(m, 11 H, 2 Ph and H-6), 7.09 (dd, J = 1, 8 Hz, 1 H, H-5), 6.76 (t, J = 6 Hz, exch., 1 H, NH), 
6.31 (d, J = 1 Hz, 1 H, H-3), 3.79 (d, J = 6 Hz, 2 H, CH2), 2.75 [s, 6 H, N(CH3)2], 2.08 (s, 3 H, 
CH3). 13C NMR (100 MHz, DMSO-d6): δ = 159.3 (C=O), 149.1 (C-1 of 2 Ph), 145.3 (C-2), 
138.2 (C-1), 135.1 (C-4), 130.7 (C-3), 130.2 (C-6), 129.4 (C-5), 128.9 (C-3/C-5 of 2 Ph), 128.5 
(C-2/C-6 of 2 Ph), 127.4 (C-4 of 2 Ph), 81.9 (C-OH), 42.8 (CH2), 36.7 [N(CH3)2], 21.8 (CH3). 
HRMS (ES+): m/z calcd for C24H27N2O2 [MH]+: 375.2067; found: 375.2072. 
N'-(2-Ethyl-4-methylbenzyl)-N,N-dimethylurea (69). 0.35 g (1.59 mmol, 80%). Mp 60–62 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.08 (d, J = 8 Hz, 1 H, H-6), 6.95 (s, 1 H, H-3), 6.91 (d, J = 8 
Hz, 1 H, H-5), 4.38 (br, exch., 1 H, NH), 4.31 (br, 2 H, CH2N), 2.58 (q, J = 7 Hz, 2 H, CH2CH3), 
2.25 [s, 6 H, N(CH3)2], 2.25 (s, 3 H, CH3), 1.14 (t, J = 7 Hz, 3 H, CH2CH3). 13C NMR (100 
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MHz, CDCl3): δ = 158.6 (C=O), 142.9 (C-1), 137.8 (C-2), 133.7 (C-4), 130.0 (C-3), 129.5 (C-6), 
127.2 (C-5), 42.9 (CH2NH), 36.6 [N(CH3)2], 25.8 (CH2CH3), 21.5 (CH3), 16.0 (CH2CH3). 
HRMS (CI): m/z calcd for C13H21N2O [MH]+: 221.1648; found: 221.1649. 
N'-(2-Deuterio-4-methylbenzyl)-N,N-dimethylurea (70). 0.33 g (1.71 mmol, 86%). Mp 97–98 
°C (Mp of undeuteriated analogue 93 °C 19). 1H NMR (400 MHz, CDCl3): δ = 7.23–7.14 (m, 3 
H, H-3, H-5 and H-6), 4.73 (br, exch., 1 H, NH), 4.38 (br, 2 H, CH2), 2.92 [s, 6 H, N(CH3)2], 
2.35 (s, 3 H, CH3). 13C NMR (100 MHz, CDCl3): δ = 158.8 (C=O), 137.3 (C-1), 137.0 (C-4), 
129.6 (C-3), 129.5 (C-5), 128.2 (C-6), 127.9 (seen as three lines, 1:1:1, because of coupling to D, 
C-2), 45.2 (CH2), 36.7 [N(CH3)2], 21.5 (CH3). HRMS (CI): m/z calcd for C11H16DN2O [MH]+: 
194.1398; found: 194.1398. 
N'-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methoxybenzyl)-N,N-dimethylurea (71). 0.59 
g (1.71 mmol; 85%). Mp 137–138 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.21 (d, J = 9 Hz, 2 
H, H-2/H-6 of 4-methoxyphenyl), 7.14 (d, J = 8 Hz, 1 H, H-6), 7.03 (d, J = 2 Hz, 1 H, H-3), 6.86 
(d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 6.78 (dd, J = 2, 8 Hz, 1 H, H-5), 6.53 (app. t, J 
= 6 Hz, exch., 1 H, NH), 5.88 (d, J = 5 Hz, 1 H, CH), 5.81 (d, J = 5 Hz, exch., 1 H, OH), 4.21 
(dd, J = 6, 14 Hz, 1 H, CHaHb), 3.96 (dd, J = 6, 14 Hz, 1 H, CHaHb), 3.73 (app. s, 6 H, 2 OCH3), 
2.77 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, DMSO-d6): δ = 159.0 (C=O), 158.9 (C-4), 158.8 
(C-4 of 4-methoxyphenyl), 144.8 (C-2), 137.3 (C-1 of 4-methoxyphenyl), 130.3 (C-1), 129.9 (C-
6), 129.0 (C-2/C-6 of 4-methoxyphenyl), 114.2 (C-3/C-5 of 4-methoxyphenyl), 113.2 (C-3), 
112.4 (C-5), 71.2 (CH), 55.9 (OCH3), 55.8 (OCH3), 41.2 (CH2), 36.7 [N(CH3)2]. HRMS (ES+): 
m/z calcd for C19H25N2O4 [MH]+: 345.1809; found: 345.1811. Anal. Calcd for C19H24N2O4: C, 
66.26; H, 7.02; N, 8.13. Found: C, 66.23; H, 7.04; N, 8.05. 
N'-(2-(Hydroxyphenylmethyl)-4-methoxybenzyl)-N,N-dimethylurea (72). 0.56 g (1.78 mmol, 
89%). Colourless oil. 1H NMR (400 MHz, CDCl3): δ = 7.27–7.12 (m, 6 H, Ph and H-6), 6.81 (d, 
J = 2 Hz, 1 H, H-3), 6.66 (dd, J = 2, 8 Hz, 1 H, H-5), 5.89 (d, J = 4 Hz, 1 H, CH), 4.80 (app. t, J 
= 6 Hz, exch., 1 H, NH), 4.68 (d, J = 4 Hz, exch., 1 H, OH), 4.21 (dd, J = 6, 14 Hz, 1 H, CHaHb), 
4.08 (dd, J = 6, 14 Hz, 1 H, CHaHb), 3.64 (s, 3 H, OCH3), 2.58 [s, 6 H, N(CH3)2]. 13C NMR (100 
MHz, CDCl3): δ = 159.3 (C=O), 158.7 (C-4), 144.0 (C-1 of Ph), 143.8 (C-2), 132.1 (C-6), 129.8 
(C-1), 128.7 (C-3/C-5 of Ph), 127.6 (C-4 of Ph), 127.2 (C-2/C-6 of Ph), 114.6 (C-5), 113.3 (C-3), 
73.7 (CH), 55.6 (OCH3), 42.1 (CH2), 36.4 [N(CH3)2]. HRMS (CI): m/z calcd for C18H23N2O3 
[MH]+: 315.3869; found: 315.3866. 
N'-(2-(Hydroxydiphenylmethyl)-4-methoxybenzyl)-N,N-dimethylurea (73). 0.66 g (1.69 
mmol, 84%). Mp 223–224 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.48 (s, exch., 1 H, OH), 
7.36–7.18 (m, 11 H, H-6 and 2 Ph), 6.78 (dd, J = 2, 8 Hz, 1 H, H-5), 6.64 (t, J = 6 Hz, exch., 1 H, 
NH), 6.01 (d, J = 2 Hz, 1 H, H-3), 3.75 (d, J = 6 Hz, 2 H, CH2), 3.54 (s, 3 H, OCH3), 2.76 [s, 6 
H, N(CH3)2]. 13C NMR (100 MHz, DMSO-d6): δ = 159.3 (C=O), 157.6 (C-4), 148.9 (C-1 of 2 
Ph), 146.9 (C-2), 132.8 (C-1), 132.4 (C-6), 128.3 (C-3/C-5 of 2 Ph), 128.1 (C-2/C-6 of 2 Ph), 
127.2 (C-4 of 2 Ph), 116.8 (C-3), 112.3 (C-5), 81.8 (C-OH), 55.4 (OCH3), 42.5 (CH2), 36.6 
[N(CH3)2]. HRMS (ES+): m/z calcd for C24H26N2O3Na [M + Na]+: 413.1836; found: 413.1837. 
ISSN 1551-7012 Page 293 ©ARKAT USA, Inc. 
General Papers  ARKIVOC 2009 (xiv) 266-300 
N'-(2-Deuterio-4-methoxybenzyl)-N,N-dimethylurea (74). 0.36 g (1.72 mmol, 86%). Mp 81–
82 °C (Mp of undeuteriated analogue 81-82 °C19). 1H NMR (400 MHz, CDCl3): δ = 7.18 (d, J = 
8 Hz, 1 H, H-6), 6.80–6.77 (m, 2 H, H-3 and H-5), 4.30 (br t, exch., 1 H, NH), 4.28 (d, J = 6 Hz, 
2 H, CH2), 3.72 (s, 3 H, OCH3), 2.83 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, CDCl3): δ = 159.3 
(C=O), 158.7 (C-4), 132.0 (C-1), 29.5 (C-6), 129.2 (seen as three lines, 1:1:1, because of 
coupling to D, C-2), 114.4 (C-3), 114.3 (C-5), 55.7 (OCH3), 44.9 (CH2), 36.7 [N(CH3)2]. HRMS 
(CI): m/z calcd for C11H16DN2O2 [MH]+: 210.1347; found: 210.1349. 
N'-(2-Ethyl-4-methoxybenzyl)-N,N-dimethylurea (75). 0.42 g (1.77 mmol, 88%). Mp 90–91 
°C. 1H NMR (400 MHz, CDCl3): δ = 7.21 (d, J = 8 Hz, 1 H, H-6), 6.78 (d, J = 2 Hz, 1 H, H-3), 
6.73 (dd, J = 2, 8 Hz, 1 H, H-5), 4.38 (br, 3 H, CH2N and NH), 3.81 (s, 3 H, OCH3), 2.91 [s, 6 H, 
N(CH3)2], 2.68 (q, J = 7 Hz, 2 H, CH2CH3), 1.24 (t, J = 7 Hz, 3 H, CH2CH3). 13C NMR (100 
MHz, CDCl3): δ = 159.6 (C=O), 158.6 (C-4), 144.7 (C-2), 130.9 (C-6), 129.0 (C-1), 115.0 (C-3), 
111.3 (C-5), 55.6 (OCH3), 42.7 (CH2NH), 36.6 [N(CH3)2], 26.0 (CH2CH3), 15.8 (CH2CH3). 
HRMS (CI): m/z calcd for C13H21N2O2 [MH]+: 237.1598; found: 237.1599. 
N'-(4-Chloro-2-(hydroxy-(4-methoxyphenyl)methyl)benzyl)-N,N-dimethylurea (76). 0.55 g 
(1.58 mmol, 79%). Mp 186–188 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.50 (s, 1 H, H-3), 7.30 
(d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.25 (d, J = 8 Hz, 1 H, H-5), 7.22 (d, J = 8 Hz, 
1 H, H-6), 6.90 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 6.65 (app. t, J = 6 Hz, exch., 1 
H, NH), 5.95 (s, exch., 1 H, OH), 5.90 (s, 1 H, CH), 4.30 (dd, J = 6, 14 Hz, 1 H, CHaHb), 4.00 
(dd, J = 6, 14 Hz, 1 H, CHaHb), 3.75 (s, 3 H, OCH3), 2.80 [s, 6 H, N(CH3)2]. 13C NMR (125 
MHz, DMSO-d6): δ = 158.8 (C=O), 158.5 (C-4 of 4-methoxyphenyl), 145.3 (C-1), 137.0 (C-1 of 
4-methoxyphenyl), 136.3 (C-2), 131.5 (C-4), 129.8 (C-5 ), 128.6 (C-2/C-6 of 4-methoxyphenyl), 
126.7 (C-3), 126.5 (C-6), 113.8 (C-3/C-5 of 4-methoxyphenyl), 70.4 (CH), 55.3 (OCH3), 36.1 
(CH2), 29.5 [N(CH3)2]. HRMS (ES+): m/z calcd for C18H22N2O335Cl [MH]+: 349.1319; found: 
349.1334. 
N'-(4-Chloro-2-(hydroxyphenylmethyl)benzyl)-N,N-dimethylurea (77). 0.50 g (1.57 mmol, 
79%). Mp 190–192 ºC. 1H NMR (500MHz, DMSO-d6): δ = 7.45 (s, 1 H, H-3), 7.35-7.28 (m, 5 
H, Ph), 7.22 (d, J = 8 Hz, 1 H, H-5), 7.20 (d, J = 8 Hz, 1 H, H-6), 6.72 (app. t, J = 6 Hz, exch., 1 
H, NH), 6.05 (s, exch., 1 H, OH), 5.95 (s, 1 H, CH), 4.30 (dd, J = 6, 14 Hz, 1 H, CHaHb), 4.05 
(dd, J = 6, 14 Hz, 1 H, CHaHb), 2.79 [s, 6 H, N(CH3)2]. 13C NMR (125 MHz, DMSO-d6): δ = 
158.5 (C=O), 145.0 (C-1 of Ph), 144.2 (C-1), 137.1 (C-2), 131.5 (C-4), 129.8 (C-6), 128.6 (C-
3/C-5 of Ph), 127.5 (C-2/C-6 of Ph), 127.4 (C-3), 127.0 (C-4 of Ph), 126.7 (C-5), 70.7 (CH), 
40.8 (CH2), 36.3 [N(CH3)2]. HRMS (ES+): m/z calcd for C17H17N2O35Cl [M – H2O]+: 300.1029; 
found: 300.1026. 
N'-(4-Chloro-2-ethylbenzyl)-N,N-dimethylurea (78). 0.37 g (1.53 mmol, 78%). Mp 102–104 
ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.25 (s, 1 H, H-3), 7.20 (d, J = 8 Hz, 1 H, H-5), 7.18 (d, 
J = 8 Hz, 1 H, H-6), 6.80 (t, J = 6 Hz, exch., 1 H, NH), 4.22 (d, J = 6 Hz, 2 H, CH2N), 2.82 [s, 6 
H, N(CH3)2], 2.62 (q, J = 7 Hz, 2 H, CH2CH3), 1.15 (t, J = 7 Hz, 3 H, CH2CH3). 13C NMR (125 
MHz, DMSO-d6): δ = 158.6 (C=O), 144.0 (C-2), 137.8 (C-1), 131.4 (C-4), 129.7 (C-6), 128.0 
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(C-3), 125.8 (C-5), 40.8 (CH2NH), 36.4 [N(CH3)2], 24.9 (CH2CH3), 15.1 (CH2CH3). HRMS 
(APCI): m/z calcd for C12H18N2O35Cl [MH]+: 241.1108; found: 241.1106. 
N'-(4-Chloro-2-deuteriobenzyl)-N,N-dimethylurea (79). 0.38 g (1.58 mmol, 79%). Mp 133-
135 ºC (Mp of undeuteriated analogue 133-135 °C10). 1H NMR (500 MHz, CDCl3): δ = 7.30 (d, 
J = 8 Hz, 1 H, H-5), 7.20 (s, 1 H, H-3), 7.17 (d, J = 8 Hz, 1 H, H-6), 4.92 (br, exch., 1 H, NH), 
4.35 (d, J = 6 Hz, 2 H, CH2), 2.90 [s, 6 H, N(CH3)2]. 13C NMR (125 MHz, CDCl3): δ = 158.3 
(C=O), 138.4 (C-1), 132.8 (C-4), 128.9 (seen as three lines, 1:1:1, because of coupling to D, C-
2), 128.7 (C-3), 128.6 (C-5), 128.5 (C-6), 44.2 (CH2), 36.2 [N(CH3)2]. HRMS (APCI): m/z calcd 
for C10H13DN2O35Cl [MH]+: 241.0857; found: 214.0851. 
N'-(4-Fluoro-2-(hydroxy-(4-methoxyphenyl)methyl)benzyl)-N,N-dimethylurea (80). 0.55 g 
(1.65 mmol, 83%). Mp 197–199 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.20-7.10 (m, 3 H, H-
3, H-5 and H-6), 7.10 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.05 (app. t, J = 6 Hz, 
exch., 1 H, NH), 6.85 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 6.65 (s, exch., 1 H, OH), 
5.91 (s, 1 H, CH), 4.29 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.95 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.72 
(s, 3 H, OCH3), 2.80 [s, 6 H, N(CH3)2]. 13C NMR (125 MHz, DMSO-d6): δ = 161.6 (seen as two 
lines because of coupling to F, J = 241 Hz, C-4), 158.8 (C=O), 158.5 (C-4 of 4-methoxyphenyl), 
145.7 (seen as two lines because of coupling to F, J = 3 Hz, C-1), 136.3 (C-1 of 
4-methoxyphenyl), 133.8 (seen as two lines because of coupling to F, J = 7 Hz, C-2), 129.8 (seen 
as two lines because of coupling to F, J = 7 Hz, C-6), 128.8 (C-2/C-6 of 4-methoxyphenyl), 
114.0 (C-3/C-5 of 4-methoxyphenyl), 113.5 (seen as two lines because of coupling to F, J = 22 
Hz, C-3), 113.2 (seen as two lines because of coupling to F, J = 22 Hz, C-5), 70.3 (CH), 55.5 
(OCH3), 40.2 (CH2), 36.3 [N(CH3)2]. HRMS (ES+): m/z calcd for C18H22N2O3F [MH]+: 
333.1614; found: 333.1601. 
N'-(4-Fluoro-2-(hydroxyphenylmethyl)benzyl)-N,N-dimethylurea (81). 0.50 g (1.65 mmol, 
83%). Mp 165–167 ºC. 1H NMR (500 MHz, DMSO-d6): δ = 7.38-7.21 (m, 7 H, Ph, H-5 and H-
6), 7.05 (m, 1 H, H-3), 6.7 (app. t, J = 6 Hz, exch., 1 H, NH), 6.05 (d, J = 4 Hz, exch., 1 H, OH), 
6.0 (d, J = 4 Hz, 1 H, CH), 4.30 (dd, J = 6, 14 Hz, 1 H, CHaHb), 4.05 (dd, J = 6, 14 Hz, 1 H, 
CHaHb), 2.80 [s, 6 H, N(CH3)2]. 13C NMR (125 MHz, DMSO-d6): δ = 161.6 (seen as two lines 
because of coupling to F, J = 247 Hz, C-4), 158.5 (C=O), 145.4 (seen as two lines because of 
coupling to F, J = 3 Hz, C-1), 144.3 (C-1 of Ph), 134.0 (seen as two lines because of coupling to 
F, J = 8 Hz, C-2), 130.0 (seen as two lines because of coupling to F, J = 8 Hz, C-6), 130.0 (C-4 
of Ph), 128.6 (C-3/C-5 of Ph), 127.5 (C-2/C-6 of Ph), 113.7 (seen as two lines because of 
coupling to F, J = 22 Hz, C-3), 113.4 (seen as two lines because of coupling to F, J = 22 Hz, C-
5), 70.7 (CH), 40.2 (CH2), 36.3 [N(CH3)2]. HRMS (APCI): m/z calcd for C17H20N2O2F [MH]+: 
303.1509; found: 303.1497. 
N'-(2-Deuterio-4-fluorobenzyl)-N,N-dimethylurea (82). 0.34 g (1.72 mmol, 86%). Mp 112–
114 ºC (Mp of undeuteriated analogue 112–114 °C10). 1H NMR (500 MHz, CDCl3): δ = 7.18 (m, 
1 H, H-6), 6.90-6.85 (m, 2 H, H-3 and H-5), 5.05 (s, exch., 1 H, NH), 4.25 (d, J = 6 Hz, 2 H, 
CH2), 2.80 [s, 6 H, N(CH3)2]. 13C NMR (125 MHz, CDCl3): δ = 161.9 (seen as two lines because 
of coupling to F, J = 246 Hz, C-4), 158.4 (C=O), 135.7 (seen as two lines because of coupling to 
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F, J = 3 Hz, C-1), 129.1 (seen as two lines because of coupling to F, J = 8 Hz, C-6), 128.8 (seen 
as six lines because of coupling to F and D, J = 8, 24 Hz, C-2), 115.2 (seen as two lines because 
of coupling to F, J = 12 Hz, C-3), 115.0 (seen as two lines because of coupling to F, J = 12 Hz, 
C-5), 44.1 (CH2), 36.2 [N(CH3)2]. HRMS (APCI): m/z calcd for C10H13DN2OF [MH]+: 
198.1153; found: 198.1147. 
N'-Ethyl-N'-(2-ethyl-4-methoxybenzyl)-N,N-dimethylurea (83). The procedure was identical 
with the general one except that iodoethane (0.69 g, 4.4 mmol) was used as an electrophile. The 
reaction mixture was worked-up and the product mixture was purified by column 
chromatography (silica gel; Et2O–hexane, 1:3) to give 83 as a colourless oil. 0.48 g (1.81 mmol, 
90%). 1H NMR (400 MHz, CDCl3): δ = 7.10 (d, J = 8 Hz, 1 H, H-6), 6.68 (d, J = 2 Hz, 1 H, H-
3), 6.63 (dd, J = 2, 8 Hz, 1 H, H-5), 4.24 (s, 2 H, CH2N), 3.71 (s, 3 H, OCH3), 3.04 (q, J = 7 Hz, 
2 H, NCH2CH3), 2.74 [s, 6 H, N(CH3)2], 2.52 (q, J = 7 Hz, 2 H, CH2CH3), 1.31 (t, J = 7 Hz, 3 H, 
NCH2CH3), 1.02 (t, J = 7 Hz, 3 H, CH2CH3). 13C NMR (100 MHz, CDCl3): δ = 165.8 (C=O), 
159.2 (C-4), 144.0 (C-2), 129.4 (C-6), 127.9 (C-1), 114.9 (C-3), 110.9 (C-5), 55.6 (OCH3), 48.6 
(NCH2), 42.8 (NCH2CH3), 39.1 [N(CH3)2], 25.7 (CH2CH3), 15.0 (CH3), 13.0 (CH3). HRMS (CI): 
m/z calcd for C15H25N2O2 [MH]+: 265.3713; found: 265.3713. 
 
Synthesis of substituted N'-benzyl-N,N-dimethylureas 85-94 via lithiation of 
N'-(2-methoxybenzyl)-N,N-dimethylurea (84) at –20 °C 
A solution of t-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a cold (-20 °C), stirred 
solution of 84 (0.42 g, 2.0 mmol) in anhydrous THF (20 mL) under N2. The mixture was stirred 
at –20 °C for 2 h after which an electrophile (2.2 mmol), in anhydrous THF (8 mL) if solid, 
otherwise neat, was added. The mixture was stirred for 2 h at -20 °C then the cooling bath was 
removed and the mixture allowed to warm to room temperature. It was then diluted with Et2O 
(10 mL) and quenched with aq. sat. NH4Cl (10 mL). The organic layer was separated, washed 
with H2O (2 x 10 mL), dried (MgSO4), and evaporated under reduced pressure. The product 
mixture was separated by column chromatography (silica gel; Et2O–hexane, 1:3) to give the pure 
product. 
N'-(2-(Hydroxy-(4-methoxyphenyl)methyl)-6-methoxybenzyl)-N,N-dimethylurea (85). 0.34 
g (0.99 mmol, 49%). Mp: 139–140 °C. 1H NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 9 Hz, 2 H, 
H-2/H-6 of 4-methoxyphenyl), 7.10 (app. t, J = 8 Hz, 1 H, H-4), 6.78–6.72 (m, 4 H, H-3, H-5 
and H-3/H-5 of 4-methoxyphenyl), 6.12 (d, J = 6 Hz, exch., 1 H, OH), 6.02 (d, J = 6 Hz, 1 H, 
CH), 5.23 (app. t, J = 6 Hz, exch., 1 H, NH), 4.30 (dd, J = 6, 16 Hz, 1 H, CHaHb), 4.22 (dd, J = 
6, 16 Hz, 1 H, CHaHb), 3.78 (s, 3 H, OCH3), 3.70 (s, 3 H, OCH3), 2.72 [s, 6 H, N(CH3)2]. 13C 
NMR (100 MHz, CDCl3): δ = 159.2 (C=O), 158.9 (C-6), 158.7 (C-4 of 4-methoxyphenyl), 144.6 
(C-2), 137.1 (C-1 of 4-methoxyphenyl), 128.8 (C-4), 127.8 (C-2/C-6 of 4-methoxyphenyl), 126.1 
(C-1), 122.4 (C-3), 113.8 (C-3/C-5 of 4-methoxyphenyl), 110.2 (C-5), 73.3 (CH), 56.0 (OCH3), 
55.6 (OCH3), 37.2 (CH2), 36.5 [N(CH3)2]. HRMS (ES+): m/z calcd for C19H25N2O4 [MH]+: 
345.1809; found: 345.1807. 
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N'-(3-(Hydroxy-(4-methoxyphenyl)methyl)-2-methoxybenzyl)-N,N-dimethylurea (86). 0.28 
g (0.81 mmol, 40%). Mp: 140–141 °C. 1H NMR (400 MHz, CDCl3): δ = 7.24 (dd, J = 2, 8 Hz, 1 
H, H-4), 7.19 (d, J = 9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.16 (br d, J = 8 Hz, 1 H, H-6), 
7.01 (app. t, J = 8 Hz, 1 H, H-5), 6.75 (d, J = 9 Hz, 2 H, H-3/H-5 of 4-methoxyphenyl), 5.96 (s, 1 
H, CH), 5.44 (s, exch., 1 H, OH), 4.81 (app. t, J = 6 Hz, exch., 1 H, NH), 4.36 (dd, J = 6, 16 Hz, 
1 H, CHaHb), 4.32 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.69 (s, 3 H, OCH3), 3.49 (s, 3 H, OCH3), 
2.78 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, CDCl3): δ = 159.3 (C=O), 158.9 (C-2), 156.0 (C-4 
of 4-methoxyphenyl), 137.8 (C-1 of 4-methoxyphenyl), 136.4 (C-1), 133.0 (C-3), 129.3 (C-4), 
128.3 (C-2/C-6 of 4-methoxyphenyl), 127.6 (C-6), 125.0 (C-5), 114.1 (C-3/C-5 of 4-
methoxyphenyl), 71.2 (CH), 62.1 (OCH3), 55.6 (OCH3), 40.3 (CH2), 36.6 [N(CH3)2]. HRMS 
(CI): m/z calcd for C19H25N2O4 [MH]+: 345.1809; found: 345.1813. 
N'-(2-(Hydroxyphenylmethyl)-6-methoxybenzyl)-N,N-dimethylurea (87). 0.32 g (1.02 mmol, 
51%). Mp: 126–127 °C. 1H NMR (400 MHz, CDCl3): δ = 7.45 (d, J = 8 Hz, 2 H, H-2/H-6 of 
Ph), 7.34 (app. t, J = 8 Hz, 2 H, H-3/H-5 of Ph), 7.32–7.20 (m, 2 H, H-4 and H-4 of Ph), 6.86 
(dd, J = 1, 8 Hz, 1 H, H-3), 6.82 (dd, J = 1, 8 Hz, 1 H, H-5), 6.41 (d, J = 6 Hz, exch., 1 H, OH), 
6.18 (d, J = 6 Hz, 1 H, CH), 5.36 (app. t, J = 6 Hz, exch., 1 H, NH), 4.41 (dd, J = 6, 16 Hz, 1 H, 
CHaHb), 4.32 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.90 (s, 3 H, OCH3), 2.85 [s, 6 H, N(CH3)2]. 13C 
NMR (100 MHz, CDCl3): δ = 159.2 (C=O), 159.0 (C-6), 144.9 (C-1 of Ph), 144.5 (C-2), 128.8 
(C-4), 128.4 (C-3/C-5 of Ph), 126.9 (C-4 of Ph), 126.7 (C-2/C-6 of Ph), 126.3 (C-1), 122.8 (C-3), 
110.3 (C-5), 73.7 (CH), 56.0 (OCH3), 37.3 (CH2), 36.5 [N(CH3)2]. HRMS (CI): m/z calcd for 
C18H23N2O3 [MH]+: 315.1703; found: 315.1702. 
N'-(3-Hydroxyphenylmethyl)-2-methoxybenzyl)-N,N-dimethylurea (88). 0.24 g (0.76 mmol, 
38%). Mp: 146–147 °C. 1H NMR (400 MHz, CDCl3): δ = 7.32 (d, J = 8 Hz, 2 H, H-2/H-6 of 
Ph), 7.26 (app. t, J = 8 Hz, 2 H, H-3/H-5 of Ph), 7.21–7.15 (m, 4 H, H-4, H-5, H-6 and OH), 7.01 
(t, J = 8 Hz, 1 H, H-4 of Ph), 6.00 (s, 1 H, CH), 4.75 (app. t, J = 6 Hz, exch., 1 H, NH), 4.37 (dd, 
J = 6, 16 Hz, 1 H, CHaHb), 4.34 (dd, J = 6, 16 Hz, 1 H, CHaHb), 3.51 (s, 3 H, OCH3), 2.80 [s, 6 
H, N(CH3)2]. 13C NMR (100 MHz, CDCl3): δ = 158.8 (C=O), 156.1 (C-2), 144.2 (C-1 of Ph), 
137.6 (C-1), 133.1 (C-3), 129.5 (C-4), 128.7 (C-3/C-5 of Ph), 127.9 (C-4 of Ph), 127.8 (C-6), 
127.0 (C-2/C-6 of Ph), 125.1 (C-5), 71.8 (CH), 62.2 (OCH3), 40.4 (CH2), 36.6 [N(CH3)2]. HRMS 
(CI): m/z calcd for C18H23N2O3 [MH]+: 315.1703; found: 315.1700. Anal. Calcd for C18H22N2O3: 
C, 68.77; H, 7.05; N, 8.91. Found: C, 68.74; H, 7.06; N, 8.90. 
N'-(2-(Hydroxydiphenylmethyl)-6-methoxybenzyl)-N,N-dimethylurea (89). 0.37 g (0.95 
mmol, 47%). Mp: 218–219 °C. 1H NMR (400 MHz, DMSO-d6): δ = 7.98 (s, exch., 1 H, OH), 
7.64 (d, J = 8 Hz, 4 H, H-2/H-6 of 2 Ph), 7.31 (t, J = 8 Hz, 4 H, H-3/H-5 of 2 Ph), 7.21 (t, J = 8 
Hz, 2 H, H-4 of 2 Ph), 7.07 (app. t, J = 8 Hz, 1 H, H-4), 6.88 (br d, J = 8 Hz, 1 H, H-3), 6.31 (dd, 
J = 2, 8 Hz, 1 H, H-5), 5.48 (br t, exch., 1 H, NH), 4.04 (d, J = 6 Hz, 2 H, CH2), 3.91 (s, 3 H, 
OCH3), 2.85 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, DMSO-d6): δ = 159.8 (C=O), 159.4 (C-6), 
149.2 (C-1 of 2 Ph), 147.9 (C-2), 128.2 (C-3/C-5 of 2 Ph), 128.0 (C-2/C-6 of 2 Ph), 127.7 (C-4), 
126.9 (C-1), 126.8 (C-4 of 2 Ph), 123.5 (C-3), 110.6 (C-5), 81.4 (C-OH), 56.1 (OCH3), 39.5 
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(CH2), 36.5 [N(CH3)2]. HRMS (CI): m/z calcd for C24H27N2O3 [MH]+: 391.2016; found: 
391.2013. 
N'-(3-(Hydroxydiphenylmethyl)-2-methoxybenzyl)-N,N-dimethylurea (90). 0.24 g (0.62 
mmol, 30%). Mp: 207–209 °C. 1H NMR (400 MHz, CDCl3): δ = 7.27-6.81 (m, 13 H, 2 Ph, OH, 
H-4 and H-5), 6.42 (dd, J = 2, 8 Hz, 1 H, H-6), 4.88 (br, exch., 1 H, NH), 4.40 (d, J = 6 Hz, 2 H, 
CH2), 3.79 (s, 3 H, OCH3), 2.86 [s, 6 H, N(CH3)2]. 13C NMR (100 MHz, CDCl3): δ = 158.8 
(C=O), 158.0 (C-2), 147.0 (C-1 of 2 Ph), 133.5 (C-1), 128.7 (C-3), 128.4 (C-3/C-5 of 2 Ph), 
128.3 (C-2/C-6 of 2 Ph), 128.2 (C-4), 128.1 (C-4 of 2 Ph), 127.7 (C-6), 124.0 (C-5), 82.6 (C-
OH), 61.6 (OCH3), 40.4 (CH2), 36.7 [N(CH3)2]. HRMS (CI): m/z calcd for C24H27N2O3 [MH]+: 
391.2016; found: 391.2015. 
N'-(2-Methoxy-6-methylbenzyl)-N,N-dimethylurea (91). 0.23 g (1.03 mmol, 51%). Oil. 1H 
NMR (400 MHz, CDCl3): δ = 7.07 (app. t, J = 8 Hz, 1 H, H-4), 6.72 (d, J = 8 Hz, 1 H, H-5), 6.66 
(d, J = 8 Hz, 1 H, H-3), 4.81 (br, exch., 1 H, NH), 4.38 (d, J = 6 Hz, 2 H, CH2), 3.77 (s, 3 H, 
OCH3), 2.78 [s, 6 H, N(CH3)2], 2.37 (s, 3 H, CH3). 13C NMR (100 MHz, CDCl3): δ = 158.8 
(C=O), 158.7 (C-2), 138.9 (C-6), 128.4 (C-4), 126.4 (C-1), 124.8 (C-5), 108.5 (C-3), 55.9 
(OCH3), 37.3 (CH2), 36.6 [N(CH3)2], 20.2 (CH3). HRMS (CI): m/z calcd for C12H19N2O2 [MH]+: 
223.1441; found: 223.1441. 
N'-(2-Methoxy-3-methylbenzyl)-N,N-dimethylurea (92). 0.18 g (0.81 mmol, 40%). Oil. 1H 
NMR (400 MHz, CDCl3): δ = 7.09 (dd, J = 1, 8 Hz, 1 H, H-4), 7.02 (br d, J = 8 Hz, 1 H, H-6), 
6.91 (app. t, J = 8 Hz, 1 H, H-5), 4.84 (br, exch., 1 H, NH), 4.37 (d, J = 6 Hz, 2 H, CH2), 3.69 (s, 
3 H, OCH3), 2.82 [s, 6 H, N(CH3)2], 2.22 (s, 3 H, CH3). 13C NMR (100 MHz, CDCl3): δ = 158.8 
(C=O), 157.2 (C-2), 132.7 (C-1), 131.5 (C-3), 131.0 (C-4), 127.8 (C-6), 124.7 (C-5), 60.8 
(OCH3), 40.9 (CH2), 36.6 [N(CH3)2], 16.4 (CH3). HRMS (CI): m/z calcd for C12H19N2O2 [MH]+: 
223.1441; found: 223.1443. 
N'-(2-Ethyl-6-methoxybenzyl)-N,N-dimethylurea (93). 0.24 g (1.02 mmol, 51%). Oil. 1H 
NMR (400 MHz, CDCl3): δ = 7.19–7.14 (m, 2 H, H-4 and NH), 6.86 (d, J = 8 Hz, 1 H, H-3), 
6.68 (d, J = 8 Hz, 1 H, H-5), 4.30 (br, 2 H, CH2N), 3.74 (s, 3 H, OCH3), 3.07 (q, J = 7 Hz, 2 H, 
CH2CH3), 2.72 [s, 6 H, N(CH3)2], 1.06 (t, J = 7 Hz, 3 H, CH2CH3). 13C NMR (100 MHz, 
CDCl3): δ = 164.5 (C=O), 156.3 (C-6), 126.9 (C-4), 126.8 (C-2), 125.4 (C-1), 119.4 (C-3), 109.0 
(C-5), 54.2 (OCH3), 45.4 (CH2NH), 41.5 (CH2CH3), 37.7 [N(CH3)2], 11.8 (CH2CH3). HRMS 
(CI): m/z calcd for C13H21N2O2 [MH]+: 237.1598; found: 237.1598. 
N'-(3-Ethyl-2-methoxybenzyl)-N,N-dimethylurea (94). 0.18 g (0.76 mmol, 38%). Oil. 1H 
NMR (400 MHz, CDCl3): δ = 7.11 (app. t, J = 8 Hz, 1 H, H-5), 6.75 (d, J = 8 Hz, 1 H, H-6), 6.67 
(d, J = 8 Hz, 1 H, H-4), 4.84 (br, exch., 1 H, NH), 3.89 (d, J = 6 Hz, 2 H, CH2N), 3.78 (s, 3 H, 
OCH3), 2.77 [s, 6 H, N(CH3)2], 2.73 (q, J = 7 Hz, 2 H, CH2CH3), 1.12 (t, J = 7 Hz, 3 H, 
CH2CH3). 13C NMR (100 MHz, CDCl3): δ = 158.8 (C=O), 158.7 (C-2), 130.7 (C-1), 130.7 (C-4), 
127.7 (C-3), 124.7 (C-6), 121.9 (C-5), 55.9 (OCH3), 36.9 (CH2NH), 36.6 [N(CH3)2], 26.6 
(CH2CH3), 16.5 (CH2CH3). HRMS (CI): m/z calcd for C13H21N2O2 [MH]+: 237.1598; found: 
237.1599. 
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